99 results on '"Sabine Baumgart"'
Search Results
2. Promoting urban health and spatial resilience as contributions towards spatial justice
- Author
-
Sabine Baumgart
- Subjects
urban health ,spatial resilience ,spatial justice ,Urban groups. The city. Urban sociology ,HT101-395 - Abstract
Spatial justice has different dimensions and is to a large extent determined by its specific political-administrative context, which guides its development on the local level. In view of the varying living conditions in urban environments I would like to draw attention to the relevance of urban health as a crucial component of spatial justice. The resilience of the population, the spaces they inhabit and the urban infrastructure are closely interlinked as regards sustainability in the face of the current multiple crises. This paper aims to reflect upon the links between urban health and resilience and their contribution to spatial justice, particularly with regard to challenges in the built urban environment as visualised in the Health Map of Barton and Grant (2006). Referring to the City Resilience Profiling Tool developed by UN-Habitat (2021), my argument addresses the interfaces between urban health and resilience. Particularly essential to me is the collection and evaluation of data for monitoring spatial development which also forms the basis for public participation in planning procedures to achieve better urban health and spatial resilience. In this endeavour, special attention should be paid to neglected urban neighbourhoods and their populations. This is even more important as the current crisis requires flexible and adaptive goals and processes linked to a learning culture approach. By striving for urban health and spatial resilience in urban structures and processes spatial justice can be achieved via innovative and transformative development paths towards sustainability.
- Published
- 2023
- Full Text
- View/download PDF
3. Destinations fostering older adults’ walking for transport: a cross-sectional study from Germany
- Author
-
Pia Hasselder, Tanja Brüchert, Sabine Baumgart, and Gabriele Bolte
- Subjects
Active mobility ,Walking for transport ,Built environment ,Destinations ,Neighborhood ,Older adults ,Geriatrics ,RC952-954.6 - Abstract
Abstract Background Having destinations within walking distance can encourage older people to walk. Yet, not all destinations may be equally important. Little is known about the types of destinations fostering older adults’ walking for transport in small and medium-sized towns and rural communities. The aim of this study was to explore the associations between the availability of different destinations and walking for transport among older adults living in communities with less than 100,000 inhabitants. Methods Between May and September 2019, self-reported data from 2242 older adults (≥ 65 years) living in the Metropolitan Region Northwest (Germany) were collected within the project AFOOT – Securing urban mobility of an aging population. Data from 2137 study participants were eligible for this analysis. Logistic regression models were used to investigate the relationship between the perceived destination availability of 19 different destinations within a 20-min or 10-min walk from home, respectively, and the engagement in walking for transport. Crude and adjusted models were run separately for each destination and distance category. Exploratory subgroup analyses examined the associations between the availability of destinations within a 20-min walk from home and walking for transport stratified by gender, use of a walking aid, and car availability. Results The availability of each of the investigated destinations within a 20-min walk and of nearly all of these destinations within a 10-min walk from home was significantly positively associated with walking for transport in crude models. Most associations remained significant after adjustment for covariates. The strongest associations were found for the availability of small stores, pharmacy, and bakery. The availability of a bus stop showed the weakest associations and was not significantly associated with walking for transport after adjustment for covariates. Conclusions The provision of local amenities within walking distance may be a promising approach to foster older adults’ walking for transport in smaller communities with less than 100,000 inhabitants and to enable active and healthy aging in place. Further quantitative and qualitative research is needed to validate these findings and to better understand older adults’ walking behavior.
- Published
- 2022
- Full Text
- View/download PDF
4. A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients – indications for their potential involvement in the development of Long COVID?
- Author
-
Simon Haunhorst, Wilhelm Bloch, Florian Javelle, Karsten Krüger, Sabine Baumgart, Sebastian Drube, Christina Lemhöfer, Philipp Reuken, Andreas Stallmach, Michael Müller, Christina E. Zielinski, Mathias W. Pletz, Holger H. W. Gabriel, and Christian Puta
- Subjects
regulatory T cells (T reg) ,COVID-19 ,SARS-CoV-2 ,Long Covid ,immune system ,adaptive immunity ,Immunologic diseases. Allergy ,RC581-607 - Abstract
BackgroundRecovery from coronavirus disease 2019 (COVID-19) can be impaired by the persistence of symptoms or new-onset health complications, commonly referred to as Long COVID. In a subset of patients, Long COVID is associated with immune system perturbations of unknown etiology, which could be related to compromised immunoregulatory mechanisms.ObjectiveThe objective of this scoping review was to summarize the existing literature regarding the frequency and functionality of Tregs in convalescent COVID-19 patients and to explore indications for their potential involvement in the development of Long COVIDDesignA systematic search of studies investigating Tregs during COVID-19 convalescence was conducted on MEDLINE (via Pubmed) and Web of Science.ResultsThe literature search yielded 17 relevant studies, of which three included a distinct cohort of patients with Long COVID. The reviewed studies suggest that the Treg population of COVID-19 patients can reconstitute quantitatively and functionally during recovery. However, the comparison between recovered and seronegative controls revealed that an infection-induced dysregulation of the Treg compartment can be sustained for at least several months. The small number of studies investigating Tregs in Long COVID allowed no firm conclusions to be drawn about their involvement in the syndrome’s etiology. Yet, even almost one year post-infection Long COVID patients exhibit significantly altered proportions of Tregs within the CD4+ T cell population.ConclusionsPersistent alterations in cell frequency in Long COVID patients indicate that Treg dysregulation might be linked to immune system-associated sequelae. Future studies should aim to address the association of Treg adaptations with different symptom clusters and blood parameters beyond the sole quantification of cell frequencies while adhering to consensualized phenotyping strategies.
- Published
- 2022
- Full Text
- View/download PDF
5. PRI: Re-Analysis of a Public Mass Cytometry Dataset Reveals Patterns of Effective Tumor Treatments
- Author
-
Yen Hoang, Stefanie Gryzik, Ines Hoppe, Alexander Rybak, Martin Schädlich, Isabelle Kadner, Dirk Walther, Julio Vera, Andreas Radbruch, Detlef Groth, Sabine Baumgart, and Ria Baumgrass
- Subjects
multi-parametric analysis ,re-analysis ,combinatorial protein expression ,high-dimensional cytometry data ,mass cytometry data ,pattern perception ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Recently, mass cytometry has enabled quantification of up to 50 parameters for millions of cells per sample. It remains a challenge to analyze such high-dimensional data to exploit the richness of the inherent information, even though many valuable new analysis tools have already been developed. We propose a novel algorithm “pattern recognition of immune cells (PRI)” to tackle these high-dimensional protein combinations in the data. PRI is a tool for the analysis and visualization of cytometry data based on a three or more-parametric binning approach, feature engineering of bin properties of multivariate cell data, and a pseudo-multiparametric visualization. Using a publicly available mass cytometry dataset, we proved that reproducible feature engineering and intuitive understanding of the generated bin plots are helpful hallmarks for re-analysis with PRI. In the CD4+T cell population analyzed, PRI revealed two bin-plot patterns (CD90/CD44/CD86 and CD90/CD44/CD27) and 20 bin plot features for threshold-independent classification of mice concerning ineffective and effective tumor treatment. In addition, PRI mapped cell subsets regarding co-expression of the proliferation marker Ki67 with two major transcription factors and further delineated a specific Th1 cell subset. All these results demonstrate the added insights that can be obtained using the non-cluster-based tool PRI for re-analyses of high-dimensional cytometric data.
- Published
- 2022
- Full Text
- View/download PDF
6. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis
- Author
-
Martina Bertolo, Sabine Baumgart, Pawel Durek, Anette Peddinghaus, Henrik Mei, Thomas Rose, Philipp Enghard, and Andreas Grützkau
- Subjects
systemic lupus – erythematosus ,lupus nephritis ,lupus nephritis biomarker ,mass cytometry ,urinary leukocytes ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Non-invasive biomarkers are necessary for diagnosis and monitoring disease activity in lupus nephritis (LN) to circumvent risks and limitations of renal biopsies. To identify new non-invasive cellular biomarkers in the urine sediment of LN patients, which may reflect kidney inflammation and can be used to predict treatment outcome, we performed in-depth urinary immune cell profiling by mass cytometry. We established a mass cytometric workflow to comparatively analyze the cellular composition of urine and peripheral blood (PB) in 13 patients with systemic lupus erythematosus (SLE) with active, biopsy-proven proliferative LN. Clinical and laboratory data were collected at the time of sampling and 6 months after induction of therapy in order to evaluate the clinical response of each patient. Six patients with different acute inflammatory renal diseases were included as comparison group. Leukocyte phenotypes and composition differed significantly between urine and paired PB samples. In urine, neutrophils and monocytes/macrophages were identified as the most prominent cell populations comprising together about 30%–83% of nucleated cells, while T and B lymphocytes, eosinophils, and natural killer (NK) cells were detectable at frequencies of
- Published
- 2020
- Full Text
- View/download PDF
7. Persistent T-Cell Reactivity in a Seronegative Patient after SARS-CoV-2 Infection and One Vaccination
- Author
-
Nico Andreas, Sebastian Weis, Steffi Kolanos, Sabine Baumgart, Thomas Kamradt, and Mathias W. Pletz
- Subjects
CoNAN ,Neustadt am Rennsteig ,COVID-19 ,SARS-CoV-2 ,T cell responses ,T immunity ,Medicine - Abstract
We present here a 64-year-old male participant of the CoNAN study who experienced a PCR-confirmed mild SARS-CoV-2 infection but did not develop any measurable antibody response. Additionally, after vaccination with ChAdOx1 (AstraZeneca, Cambridge, UK) 11 months later, no antibodies were detected in six serological tests three weeks after the vaccination. When we assessed T-helper (Th) cell immunity, SARS-CoV-2-specific Th cells produced detectable amounts of IFNγ and TNF six weeks after the infection. A robust T-cell immunity remained detectable at least until six months after the infection and was boosted by the vaccination thereafter. This case report points out that an assessment of a prior infection or a vaccine response based solely on antibody detection might have limitations in individual patients.
- Published
- 2022
- Full Text
- View/download PDF
8. Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia—A Case Report
- Author
-
Albrecht Günther, Dirk Brämer, Mathias W. Pletz, Thomas Kamradt, Sabine Baumgart, Thomas E. Mayer, Michael Baier, Angelina Autsch, Christian Mawrin, Linda Schönborn, Andreas Greinacher, and Thomas Thiele
- Subjects
vaccine ,COVID-19 ,thrombocytopenia ,cerebral thrombosis ,autoimmune ,case report ,Medicine - Abstract
Background and Objectives: Vaccine induced thrombotic thrombocytopenia (VITT) may occur after COVID-19 vaccination with recombinant adenoviral vector-based vaccines. VITT can present as cerebral sinus and venous thrombosis (CSVT), often complicated by intracranial hemorrhage. Today it is unclear, how long symptomatic VITT can persist. Here, we report the complicated long-term course of a VITT patient with extremely high titers of pathogenic anti-platelet factor 4 (PF4)-IgG antibodies. Methods: Clinical and laboratory findings are presented, including the course of platelet counts, D-Dimer levels, clinical presentation, imaging, SARS-CoV-2-serological and immunological, platelet activating anti-PF4-IgG, as well as autopsy findings. Results: The patient presented with extended superior sagittal sinus thrombosis with accompanying bifrontal intracerebral hemorrhage. Repeated treatment with intravenous immune globuline (IVIG) resolved recurrent episodes of thrombocytopenia. Moreover, the patient’s serum remained strongly positive for platelet-activating anti-PF4-IgG over three months. After a period of clinical stabilization, the patient suffered a recurrent and fatal intracranial hemorrhage. Conclusions: Complicated VITT with extremely high anti-PF4-IgG titers over three months can induce recurrent thrombocytopenia despite treatment with IVIG and anticoagulation. Plasma exchange, immunoadsorption, and /or immunosuppressive treatment may be considered in complicated VITT to reduce extraordinarily high levels of anti-PF4-IgG. Long-term therapy in such cases must take the individual bleeding risk and CSVT risk into account.
- Published
- 2021
- Full Text
- View/download PDF
9. Determinanten des Online-Einkaufs – eine empirische Studie in sechs nordrhein-westfälischen Stadtregionen
- Author
-
Claus-C. Wiegandt, Sabine Baumgart, Nina Hangebruch, Linus Holtermann, Christian Krajewski, Matthias Mensing, Cordula Neiberger, Frank Osterhage, Verena Texier-Ast, Klaus Zehner, and Björn Zucknik
- Subjects
Retail trade ,E-commerce ,Online shopping ,Buyer behavior ,North Rhine-Westphalia ,Cities. Urban geography ,GF125 ,Urbanization. City and country ,HT361-384 - Abstract
Retail trade is no longer occurring in urban centres or suburban malls on the edge of cities, exclusively. It increasingly takes place online. The aim of this study is to examine the determining factors for in-store and online shopping respectively. The results are based on a survey of approximately 2,900 people in the six North Rhine-Westphalian city regions of Aachen, Bochum, Bonn, Dortmund, Münster and Cologne. Depending on the distance to each particular urban centre, 26 neighbourhoods were chosen to conduct the questionnaires. In all six city regions it is apparent that instead of spatial factors selected demographic and socio-economic forces determine buyer behaviour. While gender, age and lifestyles are important in terms of online shopping, income is no longer an influencing parameter.
- Published
- 2018
10. Mass Cytometry for Detection of Silver at the Bacterial Single Cell Level
- Author
-
Yuting Guo, Sabine Baumgart, Hans-Joachim Stärk, Hauke Harms, and Susann Müller
- Subjects
mass cytometry ,metal-based cell marker ,silver quantification in single cells ,silver distribution ,bacterial heterogeneity ,silver nanoparticles ,Microbiology ,QR1-502 - Abstract
Background: Mass cytometry (Cytometry by Time of Flight, CyTOF) allows single-cell characterization on the basis of specific metal-based cell markers. In addition, other metals in the mass range such as silver can be detected per cell. Bacteria are known to be sensible to silver and a protocol was developed to measure both the number of affected cells per population and the quantities of silver per cell.Methods: For mass cytometry ruthenium red was used as a marker for all cells of a population while parallel application of cisplatin discriminated live from dead cells. Silver quantities per cell and frequencies of silver containing cells in a population were measured by mass cytometry. In addition, live/dead subpopulations were analyzed by flow cytometry and distinguished by cell sorting based on ruthenium red and propidium iodide double staining. Verification of the cells’ silver load was performed on the bulk level by using ICP-MS in combination with cell sorting. The protocol was developed by conveying both, fast and non-growing Pseudomonas putida cells as test organisms.Results: A workflow for labeling bacteria in order to be analyzed by mass cytometry was developed. Three different parameters were tested: ruthenium red provided counts for all bacterial cells in a population while consecutively applied cisplatin marked the frequency of dead cells. Apparent population heterogeneity was detected by different frequencies of silver containing cells. Silver quantities per cell were also well measurable. Generally, AgNP-10 treatment caused higher frequencies of dead cells, higher frequencies of silver containing cells and higher per-cell silver quantities. Due to an assumed chemical equilibrium of free and bound silver ions live and dead cells were associated with silver in equal quantities and this preferably during exponential growth. With ICP-MS up to 1.5 fg silver per bacterial cell were detected.Conclusion: An effective mass cytometry protocol was developed for the detection and quantification of silver in single bacterial cells of different physiological states. The silver quantities were generally heterogeneously distributed among cells in a population, the degree of which was dependent on micro-environmental conditions and on silver applied either in ion or nanoparticle-aggregated form.
- Published
- 2017
- Full Text
- View/download PDF
11. Fachmarktansiedlung – Erlebniskauf am Stadtrand
- Author
-
Sabine Baumgart and Peter M. Busse
- Subjects
Cities. Urban geography ,GF125 ,Urbanization. City and country ,HT361-384 - Abstract
Die Expansion großflächiger Betriebsformen des Einzelhandels hat mit der Ansiedlung von SB-Warenhäusern und Verbrauchermärkten die Zentrenstruktur und Nahversorgung der Bevölkerung nicht nur nachhaltig beeinflußt, sondern auch die Umsetzung räumlicher Ziele der Stadtentwicklung gefährdet. Kommunale Planung steht dabei einem fortschreitenden Konzentrationsprozeß des Handels durch Firmenaufkäufe, -übernahmen und -zusammenschlüsse gegenüber. Dies zeigt sich im Lebensmittelbereich am deutlichsten, denn hier werden 80 % des Branchenumsatzes von acht Großunternehmen kontrolliert1. Der Konzentrationsprozeß wird aber auch in anderen Branchen sichtbar, in denen die zehn größten Betriebe des “Nonfood“-Bereichs etwa 40 % des entsprechenden Gesamtumsatzes erzielen1. Hinzu kommt eine vom Handel immer wieder betonte Notwendigkeit der flexiblen Anpassung an sich ändernde Markterfordernisse und Kundenansprüche, die mit neuen Standort- und Immobilienpräferenzen der Anbieter einhergeht. Dies beinhaltet auch die Substitution von Betriebspersonal durch Fläche sowie ein Absinken des geforderten Qualifikationsniveaus der Beschäftigten. Die Entwicklung steht auch im Zusammenhang rechnergestützter Betriebsabläufe und veränderter Distributionslogistik. Der verstärkte Ansiedlungs- und Umnutzungsdruck dieser Betriebsform impliziert eine weitere Umlenkung der Kaufkraftströme und hat Funktionsschwächen, vor allem in den schwachen Subzentren, verstärkt. Diese Entwicklung stellt sich auch für die Innenstädte als eine neue Herausforderung dar. Der Einzelhandel reagiert verstärkt mit Strategien für ein “Trading up“ in Form der Reorganisation von Warenhausflächen (“Shop-in-Shop“) und durch gestalterische Aufbesserung. Braucht der Handel die City, oder braucht die City den Handel? Gibt es Chancen der räumlichen Integration großflächigen Einzelhandels in bestehende Zentrenstrukturen und Möglichkeiten neuer Formen von Nutzungsmischung und Nutzungsvielfalt für die kommunale Stadtentwicklungsplanung? Dazu sollen baulich-räumliche Entwicklungslinien aufgezeigt und ein Ansatz zur Einordnung von Fachmarkt-“Typen" unternommen werden.
- Published
- 1990
- Full Text
- View/download PDF
12. Betriebliche Standortgemeinschaften – Perspektiven gewerblicher Bestandssicherung?
- Author
-
Sabine Baumgart and Christina Scherges
- Subjects
Cities. Urban geography ,GF125 ,Urbanization. City and country ,HT361-384 - Published
- 1987
- Full Text
- View/download PDF
13. Acute resistance exercise-induced changes in IL-6, IL-10, and IL-1ra in healthy adults: a systematic review and meta-analysis
- Author
-
Miriam Ringleb, Florian Javelle, Simon Haunhorst, Wilhelm Bloch, Lena Fennen, Sabine Baumgart, Sebastian Drube, Philipp A. Reuken, Andreas Stallmach, Mathias W. Pletz, Heiko Wagner, Holger H. W. Gabriel, and Christian Puta
- Abstract
BackgroundMyokines, released from the contracting muscle, enable communication between the working muscles and other tissue. Their release during physical exercise is assumed to depend on mode, duration, and intensity.ObjectiveThe aim is to examine the acute changes in circulating levels of the myokines IL-6, IL-10, and IL-1ra induced by a bout of resistance exercise and to consider potential moderators of the results.MethodsSystematic literature search was conducted for resistance exercise intervention studies measuring IL-6, IL-10, or IL-1ra before and immediately after resistance exercise in healthy individuals. Random effects meta-analysis was performed for each myokine.ResultsA small to moderate positive effect of resistance exercise for IL-6 and a moderate to large positive effect for IL-1ra were detected. This could not be shown for IL-10. No moderators of the results were detected.ConclusionThis systematic review and meta-analysis clearly showed the immediate positive effects of an acute resistance exercise session on IL-6 and IL-1ra levels.
- Published
- 2023
- Full Text
- View/download PDF
14. A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients – Implications for Long COVID?
- Author
-
Simon Haunhorst, Wilhelm Bloch, Florian Javelle, Karsten Krüger, Sabine Baumgart, Sebastian Drube, Christina Lemhöfer, Philipp Reuken, Andreas Stallmach, Michael Müller, Christina E. Zielinski, Mathias W. Pletz, Holger H.W. Gabriel, and Christian Puta
- Abstract
BackgroundRecovery from coronavirus disease 2019 (COVID-19) can be impaired by the persistence of symptoms or new-onset health complications, commonly referred to as Long COVID. In a subset of patients, Long COVID is associated with immune system perturbations of unknown etiology, which could be related to compromised immunoregulatory mechanisms.ObjectiveThe aim of this scoping review was to investigate if regulatory T cell (Treg) dysregulation is observable beyond the acute illness and if it might be involved in Long COVID immunopathology.DesignA systematic search of studies investigating Tregs during COVID-19 convalescence was conducted on MEDLINE (via Pubmed) and Web of Science.ResultsThe literature search yielded 17 relevant studies, of which three included a distinct cohort of patients with Long COVID. The reviewed studies suggest that the Treg population of COVID-19 patients can reconstitute quantitatively and functionally during recovery. However, the comparison between recovered and seronegative controls revealed that an infection-induced dysregulation of the Treg compartment can be sustained for at least several months. The small number of studies investigating Tregs in Long COVID allowed no firm conclusions to be drawn about their involvement in the syndrome’s etiology. Yet, even almost one year post-infection Long COVID patients exhibit significantly altered proportions of Tregs within the CD4+ T cell population.ConclusionsPersistent alterations in cell frequency in Long COVID patients indicate that Treg dysregulation might be linked to immune system-associated sequelae. Future studies should aim to address the association of Treg adaptations with different symptom clusters and blood parameters beyond the sole quantification of cell frequencies while adhering to consensualized phenotyping strategies.
- Published
- 2022
- Full Text
- View/download PDF
15. Immune cell profiling reveals natural killer and T cell subpopulations to be associated with atopic dermatitis severity
- Author
-
Margitta Worm, Valerie Glatzel, Sabine Baumgart, Henrik E. Mei, Till Sörensen, Andreas Grützkau, and Guido Heine
- Subjects
Immunology ,Immunology and Allergy - Published
- 2022
16. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- Author
-
Lara Gibellini, Sussan Nourshargh, Susanna Cardell, Wlodzimierz Maslinski, Mar Felipo-Benavent, Florian Mair, Hans-Martin Jäck, Lilly Lopez, Klaus Warnatz, John Trowsdale, Diana Ordonez, Marcus Eich, William Hwang, Anne Cooke, Dirk Mielenz, Alberto Orfao, Winfried F. Pickl, Vladimir Benes, Alice Yue, T. Vincent Shankey, Maria Tsoumakidou, Virginia Litwin, Gelo Victoriano Dela Cruz, Andrea Cavani, Sara De Biasi, Larissa Nogueira Almeida, Jonathan J M Landry, Claudia Haftmann, Charlotte Esser, Ana Cumano, Anneke Wilharm, Francesco Dieli, Rudi Beyaert, Alessio Mazzoni, Burkhard Ludewig, Carlo Pucillo, Dirk H. Busch, Joe Trotter, Stipan Jonjić, Marc Veldhoen, Josef Spidlen, Aja M. Rieger, Dieter Adam, Srijit Khan, Todd A. Fehniger, Giuseppe Matarese, Maximilien Evrard, Christian Maueröder, Steffen Schmitt, Kristin A. Hogquist, Barry Moran, Raghavendra Palankar, Markus Feuerer, S Schmid, Susann Rahmig, Amy E. Lovett-Racke, James V. Watson, Megan K. Levings, Susanne Melzer, Dinko Pavlinic, Christopher M. Harpur, Christina Stehle, A. Graham Pockley, Toshinori Nakayama, Attila Tárnok, Juhao Yang, Michael Lohoff, Paulo Vieira, Francisco Sala-de-Oyanguren, Christian Kurts, Anastasia Gangaev, Alfonso Blanco, Hans Scherer, Regine J. Dress, Bruno Silva-Santos, Kiyoshi Takeda, Bimba F. Hoyer, Ilenia Cammarata, Daryl Grummitt, Isabel Panse, Günnur Deniz, Bianka Baying, Friederike Ebner, Esther Schimisky, Leo Hansmann, Thomas Kamradt, Edwin van der Pol, Daniel Scott-Algara, Anna Iannone, Giorgia Alvisi, Sebastian R. Schulz, Francesco Liotta, Irmgard Förster, Beatriz Jávega, Hans-Peter Rahn, Caetano Reis e Sousa, Livius Penter, Xuetao Cao, David P. Sester, Keisuke Goda, Peter Wurst, Iain B. McInnes, Ricardo T. Gazzinelli, Federica Piancone, Gerald Willimsky, Yotam Raz, Pärt Peterson, Wolfgang Fritzsche, Yvonne Samstag, Martin Büscher, Thomas Schüler, Susanne Hartmann, Robert J. Wilkinson, Anna E. S. Brooks, Steven L. C. Ketelaars, Catherine Sautès-Fridman, Anna Rubartelli, Petra Bacher, Katja Kobow, Marco A. Cassatella, Andrea Hauser, Henrik E. Mei, Kilian Schober, Silvia Della Bella, Graham Anderson, Michael D. Ward, Garth Cameron, Sebastian Lunemann, Katharina Kriegsmann, Katarzyna M. Sitnik, Brice Gaudilliere, Chantip Dang-Heine, Marcello Pinti, Paul Klenerman, Frank A. Schildberg, Joana Barros-Martins, Laura G. Rico, Hanlin Zhang, Christian Münz, Thomas Dörner, Jakob Zimmermann, Andrea M. Cooper, Jonni S. Moore, Andreas Diefenbach, Yanling Liu, Wolfgang Bauer, Tobit Steinmetz, Katharina Pracht, Leonard Tan, Peter K. Jani, Alan M. Stall, Petra Hoffmann, Christine S. Falk, Jasmin Knopf, Simon Fillatreau, Hans-Dieter Volk, Luis E. Muñoz, David L. Haviland, William W. Agace, Jonathan Rebhahn, Ljiljana Cvetkovic, Mohamed Trebak, Jordi Petriz, Mario Clerici, Diether J. Recktenwald, Anders Ståhlberg, Tristan Holland, Helen M. McGuire, Sa A. Wang, Christian Kukat, Thomas Kroneis, Laura Cook, Wan Ting Kong, Xin M. Wang, Britta Engelhardt, Pierre Coulie, Genny Del Zotto, Sally A. Quataert, Kata Filkor, Gabriele Multhoff, Bartek Rajwa, Federica Calzetti, Hans Minderman, Cosima T. Baldari, Jens Geginat, Hervé Luche, Gert Van Isterdael, Linda Schadt, Sophia Urbanczyk, Giovanna Borsellino, Liping Yu, Dale I. Godfrey, Achille Anselmo, Rachael C. Walker, Andreas Grützkau, David W. Hedley, Birgit Sawitzki, Silvia Piconese, Maria Yazdanbakhsh, Burkhard Becher, Ramon Bellmas Sanz, Michael Delacher, Hyun-Dong Chang, Immanuel Andrä, Hans-Gustaf Ljunggren, José-Enrique O'Connor, Ahad Khalilnezhad, Sharon Sanderson, Federico Colombo, Götz R. A. Ehrhardt, Inga Sandrock, Enrico Lugli, Christian Bogdan, James B. Wing, Susann Müller, Tomohiro Kurosaki, Derek Davies, Ester B. M. Remmerswaal, Kylie M. Quinn, Christopher A. Hunter, Andreas Radbruch, Timothy P. Bushnell, Anna Erdei, Sabine Adam-Klages, Pascale Eede, Van Duc Dang, Rieke Winkelmann, Thomas Korn, Gemma A. Foulds, Dirk Baumjohann, Matthias Schiemann, Manfred Kopf, Jan Kisielow, Lisa Richter, Jochen Huehn, Gloria Martrus, Alexander Scheffold, Jessica G. Borger, Sidonia B G Eckle, John Bellamy Foster, Anna Katharina Simon, Alicia Wong, Mübeccel Akdis, Gisa Tiegs, Toralf Kaiser, James McCluskey, Anna Vittoria Mattioli, Aaron J. Marshall, Hui-Fern Koay, Eva Orlowski-Oliver, Anja E. Hauser, J. Paul Robinson, Jay K. Kolls, Luca Battistini, Mairi McGrath, Jane L. Grogan, Natalio Garbi, Timothy Tree, Kingston H. G. Mills, Stefan H. E. Kaufmann, Wolfgang Schuh, Ryan R. Brinkman, Tim R. Mosmann, Vincenzo Barnaba, Andreas Dolf, Lorenzo Cosmi, Bo Huang, Andreia C. Lino, Baerbel Keller, René A. W. van Lier, Alexandra J. Corbett, Paul S. Frenette, Pleun Hombrink, Helena Radbruch, Sofie Van Gassen, Olivier Lantz, Lorenzo Moretta, Désirée Kunkel, Kirsten A. Ward-Hartstonge, Armin Saalmüller, Leslie Y. T. Leung, Salvador Vento-Asturias, Paola Lanuti, Alicia Martínez-Romero, Sarah Warth, Zhiyong Poon, Diana Dudziak, Andrea Cossarizza, Kovit Pattanapanyasat, Konrad von Volkmann, Jessica P. Houston, Agnès Lehuen, Andrew Filby, Pratip K. Chattopadhyay, Stefano Casola, Annika Wiedemann, Hannes Stockinger, Jürgen Ruland, Arturo Zychlinsky, Claudia Waskow, Katrin Neumann, Ari Waisman, Lucienne Chatenoud, Sudipto Bari, Kamran Ghoreschi, David W. Galbraith, Yvan Saeys, Hamida Hammad, Andrea Gori, Miguel López-Botet, Gabriel Núñez, Sabine Ivison, Michael Hundemer, Dorothea Reimer, Mark C. Dessing, Günter J. Hämmerling, Rudolf A. Manz, Tomas Kalina, Jonas Hahn, Holden T. Maecker, Hendy Kristyanto, Martin S. Davey, Henning Ulrich, Michael L. Dustin, Takashi Saito, Yousuke Takahama, Milena Nasi, Johanna Huber, Jürgen Wienands, Paolo Dellabona, Andreas Schlitzer, Michael D. Leipold, Kerstin H. Mair, Christian Peth, Immo Prinz, Chiara Romagnani, José M. González-Navajas, Josephine Schlosser, Marina Saresella, Matthias Edinger, Dirk Brenner, Nicole Baumgarth, Rikard Holmdahl, Fang-Ping Huang, Guadalupe Herrera, Malte Paulsen, Gergely Toldi, Luka Cicin-Sain, Reiner Schulte, Christina E. Zielinski, Thomas Winkler, Christoph Goettlinger, Philip E. Boulais, Jennie H M Yang, Antonio Celada, Heike Kunze-Schumacher, Julia Tornack, Florian Ingelfinger, Jenny Mjösberg, Andy Riddell, Leonie Wegener, Thomas Höfer, Christoph Hess, James P. Di Santo, Anna E. Oja, J. Kühne, Willem van de Veen, Mary Bebawy, Alberto Mantovani, Bart Everts, Giovanna Lombardi, Laura Maggi, Anouk von Borstel, Pia Kvistborg, Elisabetta Traggiai, A Ochel, Nima Aghaeepour, Charles-Antoine Dutertre, Matthieu Allez, Thomas Höllt, Wenjun Ouyang, Regina Stark, Maries van den Broek, Shimon Sakaguchi, Paul K. Wallace, Silvano Sozzani, Francesca LaRosa, Annette Oxenius, Malgorzata J. Podolska, Ivana Marventano, Wilhelm Gerner, Oliver F. Wirz, Britta Frehse, Gevitha Ravichandran, Martin Herrmann, Carl S. Goodyear, Gary Warnes, Helen Ferry, Stefan Frischbutter, Tim R. Radstake, Salomé LeibundGut-Landmann, Yi Zhao, Axel Schulz, Angela Santoni, Pablo Engel, Daniela C. Hernández, Andreas Acs, Cristiano Scottà, Francesco Annunziato, Thomas Weisenburger, Wolfgang Beisker, Sue Chow, Fritz Melchers, Daniel E. Speiser, Immanuel Kwok, Florent Ginhoux, Dominic A. Boardman, Natalie Stanley, Carsten Watzl, Marie Follo, Erik Lubberts, Andreas Krueger, Susanne Ziegler, Göran K. Hansson, David Voehringer, Antonia Niedobitek, Eleni Christakou, Lai Guan Ng, Sabine Baumgart, Nicholas A Gherardin, Antonio Cosma, Orla Maguire, Jolene Bradford, Daniel Schraivogel, Linda Quatrini, Stephen D. Miller, Rheumatology, Università degli Studi di Modena e Reggio Emilia (UNIMORE), Deutsches Rheuma-ForschungsZentrum (DRFZ), Deutsches Rheuma-ForschungsZentrum, Swiss Institute of Allergy and Asthma Research (SIAF), Universität Zürich [Zürich] = University of Zurich (UZH), Institut de Recherche Saint-Louis - Hématologie Immunologie Oncologie (Département de recherche de l’UFR de médecine, ex- Institut Universitaire Hématologie-IUH) (IRSL), Université de Paris (UP), Ecotaxie, microenvironnement et développement lymphocytaire (EMily (UMR_S_1160 / U1160)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Department of Internal Medicine, Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI)-DENOTHE Center, Institute of Clinical Molecular Biology, Kiel University, Department of Life Sciences [Siena, Italy], Università degli Studi di Siena = University of Siena (UNISI), Institut Pasteur, Fondation Cenci Bolognetti - Istituto Pasteur Italia, Fondazione Cenci Bolognetti, Réseau International des Instituts Pasteur (RIIP), Dulbecco Telethon Institute/Department of Biology, Caprotec Bioanalytics GmbH, International Occultation Timing Association European Section (IOTA ES), International Occultation Timing Association European Section, European Molecular Biology Laboratory [Heidelberg] (EMBL), VIB-UGent Center for Inflammation Research [Gand, Belgique] (IRC), VIB [Belgium], Fondazione Santa Lucia (IRCCS), Department of Immunology, Chinese Academy of Medical Sciences, FIRC Institute of Molecular Oncology Foundation, IFOM, Istituto FIRC di Oncologia Molecolare (IFOM), Institut Necker Enfants-Malades (INEM - UM 111 (UMR 8253 / U1151)), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Department of Physiopatology and Transplantation, University of Milan (DEPT), University of Milan, Monash University [Clayton], Institut des Maladies Emergentes et des Thérapies Innovantes (IMETI), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Institute of Cellular Pathology, Université Catholique de Louvain = Catholic University of Louvain (UCL), Lymphopoïèse (Lymphopoïèse (UMR_1223 / U1223 / U-Pasteur_4)), Institut Pasteur [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Experimental Immunology Unit, Dept. of Oncology, DIBIT San Raffaele Scientific Institute, Immunité Innée - Innate Immunity, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur [Paris], Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Department of Biopharmacy [Bruxelles, Belgium] (Institute for Medical Immunology IMI), Université libre de Bruxelles (ULB), Charité Hospital, Humboldt-Universität zu Berlin, Agency for science, technology and research [Singapore] (A*STAR), Laboratory of Molecular Immunology and the Howard Hughes Institute, Rockefeller University [New York], Kennedy Institute of Rheumatology [Oxford, UK], Imperial College London, Theodor Kocher Institute, University of Bern, Leibniz Research Institute for Environmental Medicine [Düsseldorf, Germany] ( IUF), Université Lumière - Lyon 2 (UL2), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), University of Edinburgh, Integrative Biology Program [Milano], Istituto Nazionale Genetica Molecolare [Milano] (INGM), Singapore Immunology Network (SIgN), Biomedical Sciences Institute (BMSI), Universitat de Barcelona (UB), Rheumatologie, Cell Biology, Department of medicine [Stockholm], Karolinska Institutet [Stockholm]-Karolinska University Hospital [Stockholm], Department for Internal Medicine 3, Institute for Clinical Immunology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Delft University of Technology (TU Delft), Medical Inflammation Research, Karolinska Institutet [Stockholm], Department of Photonics Engineering [Lyngby], Technical University of Denmark [Lyngby] (DTU), Dpt of Experimental Immunology [Braunschweig], Helmholtz Centre for Infection Research (HZI), Department of Internal Medicine V, Universität Heidelberg [Heidelberg], Department of Histology and Embryology, University of Rijeka, Freiburg University Medical Center, Nuffield Dept of Clinical Medicine, University of Oxford [Oxford]-NIHR Biomedical Research Centre, Institute of Integrative Biology, Molecular Biomedicine, Berlin Institute of Health (BIH), Laboratory for Lymphocyte Differentiation, RIKEN Research Center, Institutes of Molecular Medicine and Experimental Immunology, University of Bonn, Immunité et cancer (U932), Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Cochin (IC UM3 (UMR 8104 / U1016)), Department of Surgery [Vancouver, BC, Canada] (Child and Family Research Institute), University of British Columbia (UBC)-Child and Family Research Institute [Vancouver, BC, Canada], College of Food Science and Technology [Shangai], Shanghai Ocean University, Institute for Medical Microbiology and Hygiene, University of Marburg, King‘s College London, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Centre d'Immunophénomique (CIPHE), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Brustzentrum Kantonsspital St. Gallen, Immunotechnology Section, Vaccine Research Center, National Institutes of Health [Bethesda] (NIH)-National Institute of Allergy and Infectious Diseases, Heinrich Pette Institute [Hamburg], Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI), Department of Immunology and Cell Biology, Mario Negri Institute, Laboratory of Molecular Medicine and Biotechnology, Don C. Gnocchi ONLUS Foundation, Institute of Translational Medicine, Klinik für Dermatologie, Venerologie und Allergologie, School of Biochemistry and Immunology, Department of Medicine Huddinge, Karolinska Institutet [Stockholm]-Karolinska University Hospital [Stockholm]-Lipid Laboratory, Università di Genova, Dipartimento di Medicina Sperimentale, Department of Environmental Microbiology, Helmholtz Zentrum für Umweltforschung = Helmholtz Centre for Environmental Research (UFZ), Department of Radiation Oncology [Munich], Ludwig-Maximilians-Universität München (LMU), Centre de Recherche Publique- Santé, Université du Luxembourg (Uni.lu), William Harvey Research Institute, Barts and the London Medical School, University of Michigan [Ann Arbor], University of Michigan System, Centro de Investigacion del Cancer (CSIC), Universitario de Salamanca, Molecular Pathology [Tartu, Estonia], University of Tartu, Hannover Medical School [Hannover] (MHH), Centre d'Immunologie de Marseille - Luminy (CIML), Monash Biomedicine Discovery Institute, Cytometry Laboratories and School of Veterinary Medicine, Purdue University [West Lafayette], Data Mining and Modelling for Biomedicine [Ghent, Belgium], VIB Center for Inflammation Research [Ghent, Belgium], Laboratory for Cell Signaling, RIKEN Research Center for Allergy and Immunology, RIKEN Research Center for Allergy and Immunology, Osaka University [Osaka], Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome], Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université de Paris (UP), Institute of Medical Immunology [Berlin, Germany], FACS and Array Core Facility, Johannes Gutenberg - Universität Mainz (JGU), Otto-von-Guericke University [Magdeburg] (OVGU), SUPA School of Physics and Astronomy [University of St Andrews], University of St Andrews [Scotland]-Scottish Universities Physics Alliance (SUPA), Biologie Cellulaire des Lymphocytes - Lymphocyte Cell Biology, Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), General Pathology and Immunology (GPI), University of Brescia, Université de Lausanne (UNIL), Terry Fox Laboratory, BC Cancer Agency (BCCRC)-British Columbia Cancer Agency Research Centre, Department of Molecular Immunology, Medizinische Universität Wien = Medical University of Vienna, Dept. Pediatric Cardiology, Universität Leipzig [Leipzig], Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Center for Cardiovascular Sciences, Albany Medical College, Dept Pathol, Div Immunol, University of Cambridge [UK] (CAM), Department of Information Technology [Gent], Universiteit Gent, Department of Plant Systems Biology, Department of Plant Biotechnology and Genetics, Universiteit Gent = Ghent University [Belgium] (UGENT), Division of Molecular Immunology, Institute for Immunology, Department of Geological Sciences, University of Oregon [Eugene], Centers for Disease Control and Prevention [Atlanta] (CDC), Centers for Disease Control and Prevention, University of Colorado [Colorado Springs] (UCCS), FACS laboratory, Cancer Research, London, Cancer Research UK, Regeneration in Hematopoiesis and Animal Models of Hematopoiesis, Faculty of Medicine, Dresden University of Technology, Barbara Davis Center for Childhood Diabetes (BDC), University of Colorado Anschutz [Aurora], School of Computer and Electronic Information [Guangxi University], Guangxi University [Nanning], School of Materials Science and Engineering, Nanyang Technological University [Singapour], Max Planck Institute for Infection Biology (MPIIB), Max-Planck-Gesellschaft, Work in the laboratory of Dieter Adam is supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—Projektnummer 125440785 – SFB 877, Project B2.Petra Hoffmann, Andrea Hauser, and Matthias Edinger thank BD Biosciences®, San José, CA, USA, and SKAN AG, Bale, Switzerland for fruitful cooperation during the development, construction, and installation of the GMP‐compliant cell sorting equipment and the Bavarian Immune Therapy Network (BayImmuNet) for financial support.Edwin van der Pol and Paola Lanuti acknowledge Aleksandra Gąsecka M.D. for excellent experimental support and Dr. Rienk Nieuwland for textual suggestions. This work was supported by the Netherlands Organisation for Scientific Research – Domain Applied and Engineering Sciences (NWO‐TTW), research program VENI 15924.Jessica G Borger, Kylie M Quinn, Mairi McGrath, and Regina Stark thank Francesco Siracusa and Patrick Maschmeyer for providing data.Larissa Nogueira Almeida was supported by DFG research grant MA 2273/14‐1. Rudolf A. Manz was supported by the Excellence Cluster 'Inflammation at Interfaces' (EXC 306/2).Susanne Hartmann and Friederike Ebner were supported by the German Research Foundation (GRK 2046).Hans Minderman was supported by NIH R50CA211108.This work was funded by the Deutsche Forschungsgemeinschaft through the grant TRR130 (project P11 and C03) to Thomas H. Winkler.Ramon Bellmàs Sanz, Jenny Kühne, and Christine S. Falk thank Jana Keil and Kerstin Daemen for excellent technical support. The work was funded by the Germany Research Foundation CRC738/B3 (CSF).The work by the Mei laboratory was supported by German Research Foundation Grant ME 3644/5‐1 and TRR130 TP24, the German Rheumatism Research Centre Berlin, European Union Innovative Medicines Initiative ‐ Joint Undertaking ‐ RTCure Grant Agreement 777357, the Else Kröner‐Fresenius‐Foundation, German Federal Ministry of Education and Research e:Med sysINFLAME Program Grant 01ZX1306B and KMU‐innovativ 'InnoCyt', and the Leibniz Science Campus for Chronic Inflammation (http://www.chronische-entzuendung.org).Axel Ronald Schulz, Antonio Cosma, Sabine Baumgart, Brice Gaudilliere, Helen M. McGuire, and Henrik E. Mei thank Michael D. Leipold for critically reading the manuscript.Christian Kukat acknowledges support from the ISAC SRL Emerging Leaders program.John Trowsdale received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (Grant Agreement 695551)., European Project: 7728036(1978), Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia (UNIMORE), Université Paris Cité (UPCité), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Università degli Studi di Firenze = University of Florence (UniFI)-DENOTHE Center, Università degli Studi di Milano = University of Milan (UNIMI), Institut Pasteur [Paris] (IP)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Humboldt University Of Berlin, Leibniz Research Institute for Environmental Medicine [Düsseldorf, Germany] (IUF), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Danmarks Tekniske Universitet = Technical University of Denmark (DTU), Universität Heidelberg [Heidelberg] = Heidelberg University, Universitäts Klinikum Freiburg = University Medical Center Freiburg (Uniklinik), University of Oxford-NIHR Biomedical Research Centre, Universität Bonn = University of Bonn, Università degli Studi di Firenze = University of Florence (UniFI), Università degli studi di Genova = University of Genoa (UniGe), Universidad de Salamanca, Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA), École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Johannes Gutenberg - Universität Mainz = Johannes Gutenberg University (JGU), Otto-von-Guericke-Universität Magdeburg = Otto-von-Guericke University [Magdeburg] (OVGU), Université de Lausanne = University of Lausanne (UNIL), Universität Leipzig, Universiteit Gent = Ghent University (UGENT), HZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany., Cossarizza, A., Chang, H. -D., Radbruch, A., Acs, A., Adam, D., Adam-Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., Almeida, L. N., Alvisi, G., Anderson, G., Andra, I., Annunziato, F., Anselmo, A., Bacher, P., Baldari, C. T., Bari, S., Barnaba, V., Barros-Martins, J., Battistini, L., Bauer, W., Baumgart, S., Baumgarth, N., Baumjohann, D., Baying, B., Bebawy, M., Becher, B., Beisker, W., Benes, V., Beyaert, R., Blanco, A., Boardman, D. A., Bogdan, C., Borger, J. G., Borsellino, G., Boulais, P. E., Bradford, J. A., Brenner, D., Brinkman, R. R., Brooks, A. E. S., Busch, D. H., Buscher, M., Bushnell, T. P., Calzetti, F., Cameron, G., Cammarata, I., Cao, X., Cardell, S. L., Casola, S., Cassatella, M. A., Cavani, A., Celada, A., Chatenoud, L., Chattopadhyay, P. K., Chow, S., Christakou, E., Cicin-Sain, L., Clerici, M., Colombo, F. S., Cook, L., Cooke, A., Cooper, A. M., Corbett, A. J., Cosma, A., Cosmi, L., Coulie, P. G., Cumano, A., Cvetkovic, L., Dang, V. D., Dang-Heine, C., Davey, M. S., Davies, D., De Biasi, S., Del Zotto, G., Dela Cruz, G. V., Delacher, M., Della Bella, S., Dellabona, P., Deniz, G., Dessing, M., Di Santo, J. P., Diefenbach, A., Dieli, F., Dolf, A., Dorner, T., Dress, R. J., Dudziak, D., Dustin, M., Dutertre, C. -A., Ebner, F., Eckle, S. B. G., Edinger, M., Eede, P., Ehrhardt, G. R. A., Eich, M., Engel, P., Engelhardt, B., Erdei, A., Esser, C., Everts, B., Evrard, M., Falk, C. S., Fehniger, T. A., Felipo-Benavent, M., Ferry, H., Feuerer, M., Filby, A., Filkor, K., Fillatreau, S., Follo, M., Forster, I., Foster, J., Foulds, G. A., Frehse, B., Frenette, P. S., Frischbutter, S., Fritzsche, W., Galbraith, D. W., Gangaev, A., Garbi, N., Gaudilliere, B., Gazzinelli, R. T., Geginat, J., Gerner, W., Gherardin, N. A., Ghoreschi, K., Gibellini, L., Ginhoux, F., Goda, K., Godfrey, D. I., Goettlinger, C., Gonzalez-Navajas, J. M., Goodyear, C. S., Gori, A., Grogan, J. L., Grummitt, D., Grutzkau, A., Haftmann, C., Hahn, J., Hammad, H., Hammerling, G., Hansmann, L., Hansson, G., Harpur, C. M., Hartmann, S., Hauser, A., Hauser, A. E., Haviland, D. L., Hedley, D., Hernandez, D. C., Herrera, G., Herrmann, M., Hess, C., Hofer, T., Hoffmann, P., Hogquist, K., Holland, T., Hollt, T., Holmdahl, R., Hombrink, P., Houston, J. P., Hoyer, B. F., Huang, B., Huang, F. -P., Huber, J. E., Huehn, J., Hundemer, M., Hunter, C. A., Hwang, W. Y. K., Iannone, A., Ingelfinger, F., Ivison, S. M., Jack, H. -M., Jani, P. K., Javega, B., Jonjic, S., Kaiser, T., Kalina, T., Kamradt, T., Kaufmann, S. H. E., Keller, B., Ketelaars, S. L. C., Khalilnezhad, A., Khan, S., Kisielow, J., Klenerman, P., Knopf, J., Koay, H. -F., Kobow, K., Kolls, J. K., Kong, W. T., Kopf, M., Korn, T., Kriegsmann, K., Kristyanto, H., Kroneis, T., Krueger, A., Kuhne, J., Kukat, C., Kunkel, D., Kunze-Schumacher, H., Kurosaki, T., Kurts, C., Kvistborg, P., Kwok, I., Landry, J., Lantz, O., Lanuti, P., Larosa, F., Lehuen, A., LeibundGut-Landmann, S., Leipold, M. D., Leung, L. Y. T., Levings, M. K., Lino, A. C., Liotta, F., Litwin, V., Liu, Y., Ljunggren, H. -G., Lohoff, M., Lombardi, G., Lopez, L., Lopez-Botet, M., Lovett-Racke, A. E., Lubberts, E., Luche, H., Ludewig, B., Lugli, E., Lunemann, S., Maecker, H. T., Maggi, L., Maguire, O., Mair, F., Mair, K. H., Mantovani, A., Manz, R. A., Marshall, A. J., Martinez-Romero, A., Martrus, G., Marventano, I., Maslinski, W., Matarese, G., Mattioli, A. V., Maueroder, C., Mazzoni, A., Mccluskey, J., Mcgrath, M., Mcguire, H. M., Mcinnes, I. B., Mei, H. E., Melchers, F., Melzer, S., Mielenz, D., Miller, S. D., Mills, K. H. G., Minderman, H., Mjosberg, J., Moore, J., Moran, B., Moretta, L., Mosmann, T. R., Muller, S., Multhoff, G., Munoz, L. E., Munz, C., Nakayama, T., Nasi, M., Neumann, K., Ng, L. G., Niedobitek, A., Nourshargh, S., Nunez, G., O'Connor, J. -E., Ochel, A., Oja, A., Ordonez, D., Orfao, A., Orlowski-Oliver, E., Ouyang, W., Oxenius, A., Palankar, R., Panse, I., Pattanapanyasat, K., Paulsen, M., Pavlinic, D., Penter, L., Peterson, P., Peth, C., Petriz, J., Piancone, F., Pickl, W. F., Piconese, S., Pinti, M., Pockley, A. G., Podolska, M. J., Poon, Z., Pracht, K., Prinz, I., Pucillo, C. E. M., Quataert, S. A., Quatrini, L., Quinn, K. M., Radbruch, H., Radstake, T. R. D. J., Rahmig, S., Rahn, H. -P., Rajwa, B., Ravichandran, G., Raz, Y., Rebhahn, J. A., Recktenwald, D., Reimer, D., Reis e Sousa, C., Remmerswaal, E. B. M., Richter, L., Rico, L. G., Riddell, A., Rieger, A. M., Robinson, J. P., Romagnani, C., Rubartelli, A., Ruland, J., Saalmuller, A., Saeys, Y., Saito, T., Sakaguchi, S., Sala-de-Oyanguren, F., Samstag, Y., Sanderson, S., Sandrock, I., Santoni, A., Sanz, R. B., Saresella, M., Sautes-Fridman, C., Sawitzki, B., Schadt, L., Scheffold, A., Scherer, H. U., Schiemann, M., Schildberg, F. A., Schimisky, E., Schlitzer, A., Schlosser, J., Schmid, S., Schmitt, S., Schober, K., Schraivogel, D., Schuh, W., Schuler, T., Schulte, R., Schulz, A. R., Schulz, S. R., Scotta, C., Scott-Algara, D., Sester, D. P., Shankey, T. V., Silva-Santos, B., Simon, A. K., Sitnik, K. M., Sozzani, S., Speiser, D. E., Spidlen, J., Stahlberg, A., Stall, A. M., Stanley, N., Stark, R., Stehle, C., Steinmetz, T., Stockinger, H., Takahama, Y., Takeda, K., Tan, L., Tarnok, A., Tiegs, G., Toldi, G., Tornack, J., Traggiai, E., Trebak, M., Tree, T. I. M., Trotter, J., Trowsdale, J., Tsoumakidou, M., Ulrich, H., Urbanczyk, S., van de Veen, W., van den Broek, M., van der Pol, E., Van Gassen, S., Van Isterdael, G., van Lier, R. A. W., Veldhoen, M., Vento-Asturias, S., Vieira, P., Voehringer, D., Volk, H. -D., von Borstel, A., von Volkmann, K., Waisman, A., Walker, R. V., Wallace, P. K., Wang, S. A., Wang, X. M., Ward, M. D., Ward-Hartstonge, K. A., Warnatz, K., Warnes, G., Warth, S., Waskow, C., Watson, J. V., Watzl, C., Wegener, L., Weisenburger, T., Wiedemann, A., Wienands, J., Wilharm, A., Wilkinson, R. J., Willimsky, G., Wing, J. B., Winkelmann, R., Winkler, T. H., Wirz, O. F., Wong, A., Wurst, P., Yang, J. H. M., Yang, J., Yazdanbakhsh, M., Yu, L., Yue, A., Zhang, H., Zhao, Y., Ziegler, S. M., Zielinski, C., Zimmermann, J., Zychlinsky, A., UCL - SSS/DDUV - Institut de Duve, UCL - SSS/DDUV/GECE - Génétique cellulaire, Netherlands Organization for Scientific Research, German Research Foundation, European Commission, European Research Council, Repositório da Universidade de Lisboa, CCA - Imaging and biomarkers, Experimental Immunology, AII - Infectious diseases, AII - Inflammatory diseases, Biomedical Engineering and Physics, ACS - Atherosclerosis & ischemic syndromes, and Landsteiner Laboratory
- Subjects
0301 basic medicine ,Consensus ,Immunology ,Consensu ,Cell Separation ,Biology ,Article ,Flow cytometry ,03 medical and health sciences ,0302 clinical medicine ,Guidelines ,Allergy and Immunology ,medicine ,Cell separation ,Immunology and Allergy ,Humans ,guidelines ,flow cytometry ,immunology ,medicine.diagnostic_test ,BIOMEDICINE AND HEALTHCARE. Basic Medical Sciences ,Cell sorting ,Flow Cytometry ,Cell selection ,Data science ,3. Good health ,030104 developmental biology ,Phenotype ,[SDV.IMM]Life Sciences [q-bio]/Immunology ,BIOMEDICINA I ZDRAVSTVO. Temeljne medicinske znanosti ,030215 immunology ,Human - Abstract
All authors: Andrea Cossarizza Hyun‐Dong Chang Andreas Radbruch Andreas Acs Dieter Adam Sabine Adam‐Klages William W. Agace Nima Aghaeepour Mübeccel Akdis Matthieu Allez Larissa Nogueira Almeida Giorgia Alvisi Graham Anderson Immanuel Andrä Francesco Annunziato Achille Anselmo Petra Bacher Cosima T. Baldari Sudipto Bari Vincenzo Barnaba Joana Barros‐Martins Luca Battistini Wolfgang Bauer Sabine Baumgart Nicole Baumgarth Dirk Baumjohann Bianka Baying Mary Bebawy Burkhard Becher Wolfgang Beisker Vladimir Benes Rudi Beyaert Alfonso Blanco Dominic A. Boardman Christian Bogdan Jessica G. Borger Giovanna Borsellino Philip E. Boulais Jolene A. Bradford Dirk Brenner Ryan R. Brinkman Anna E. S. Brooks Dirk H. Busch Martin Büscher Timothy P. Bushnell Federica Calzetti Garth Cameron Ilenia Cammarata Xuetao Cao Susanna L. Cardell Stefano Casola Marco A. Cassatella Andrea Cavani Antonio Celada Lucienne Chatenoud Pratip K. Chattopadhyay Sue Chow Eleni Christakou Luka Čičin‐Šain Mario Clerici Federico S. Colombo Laura Cook Anne Cooke Andrea M. Cooper Alexandra J. Corbett Antonio Cosma Lorenzo Cosmi Pierre G. Coulie Ana Cumano Ljiljana Cvetkovic Van Duc Dang Chantip Dang‐Heine Martin S. Davey Derek Davies Sara De Biasi Genny Del Zotto Gelo Victoriano Dela Cruz Michael Delacher Silvia Della Bella Paolo Dellabona Günnur Deniz Mark Dessing James P. Di Santo Andreas Diefenbach Francesco Dieli Andreas Dolf Thomas Dörner Regine J. Dress Diana Dudziak Michael Dustin Charles‐Antoine Dutertre Friederike Ebner Sidonia B. G. Eckle Matthias Edinger Pascale Eede Götz R.A. Ehrhardt Marcus Eich Pablo Engel Britta Engelhardt Anna Erdei Charlotte Esser Bart Everts Maximilien Evrard Christine S. Falk Todd A. Fehniger Mar Felipo‐Benavent Helen Ferry Markus Feuerer Andrew Filby Kata Filkor Simon Fillatreau Marie Follo Irmgard Förster John Foster Gemma A. Foulds Britta Frehse Paul S. Frenette Stefan Frischbutter Wolfgang Fritzsche David W. Galbraith Anastasia Gangaev Natalio Garbi Brice Gaudilliere Ricardo T. Gazzinelli Jens Geginat Wilhelm Gerner Nicholas A. Gherardin Kamran Ghoreschi Lara Gibellini Florent Ginhoux Keisuke Goda Dale I. Godfrey Christoph Goettlinger Jose M. González‐Navajas Carl S. Goodyear Andrea Gori Jane L. Grogan Daryl Grummitt Andreas Grützkau Claudia Haftmann Jonas Hahn Hamida Hammad Günter Hämmerling Leo Hansmann Goran Hansson Christopher M. Harpur Susanne Hartmann Andrea Hauser Anja E. Hauser David L. Haviland David Hedley Daniela C. Hernández Guadalupe Herrera Martin Herrmann Christoph Hess Thomas Höfer Petra Hoffmann Kristin Hogquist Tristan Holland Thomas Höllt Rikard Holmdahl Pleun Hombrink Jessica P. Houston Bimba F. Hoyer Bo Huang Fang‐Ping Huang Johanna E. Huber Jochen Huehn Michael Hundemer Christopher A. Hunter William Y. K. Hwang Anna Iannone Florian Ingelfinger Sabine M Ivison Hans‐Martin Jäck Peter K. Jani Beatriz Jávega Stipan Jonjic Toralf Kaiser Tomas Kalina Thomas Kamradt Stefan H. E. Kaufmann Baerbel Keller Steven L. C. Ketelaars Ahad Khalilnezhad Srijit Khan Jan Kisielow Paul Klenerman Jasmin Knopf Hui‐Fern Koay Katja Kobow Jay K. Kolls Wan Ting Kong Manfred Kopf Thomas Korn Katharina Kriegsmann Hendy Kristyanto Thomas Kroneis Andreas Krueger Jenny Kühne Christian Kukat Désirée Kunkel Heike Kunze‐Schumacher Tomohiro Kurosaki Christian Kurts Pia Kvistborg Immanuel Kwok Jonathan Landry Olivier Lantz Paola Lanuti Francesca LaRosa Agnès Lehuen Salomé LeibundGut‐Landmann Michael D. Leipold Leslie Y.T. Leung Megan K. Levings Andreia C. Lino Francesco Liotta Virginia Litwin Yanling Liu Hans‐Gustaf Ljunggren Michael Lohoff Giovanna Lombardi Lilly Lopez Miguel López‐Botet Amy E. Lovett‐Racke Erik Lubberts Herve Luche Burkhard Ludewig Enrico Lugli Sebastian Lunemann Holden T. Maecker Laura Maggi Orla Maguire Florian Mair Kerstin H. Mair Alberto Mantovani Rudolf A. Manz Aaron J. Marshall Alicia Martínez‐Romero Glòria Martrus Ivana Marventano Wlodzimierz Maslinski Giuseppe Matarese Anna Vittoria Mattioli Christian Maueröder Alessio Mazzoni James McCluskey Mairi McGrath Helen M. McGuire Iain B. McInnes Henrik E. Mei Fritz Melchers Susanne Melzer Dirk Mielenz Stephen D. Miller Kingston H.G. Mills Hans Minderman Jenny Mjösberg Jonni Moore Barry Moran Lorenzo Moretta Tim R. Mosmann Susann Müller Gabriele Multhoff Luis Enrique Muñoz Christian Münz Toshinori Nakayama Milena Nasi Katrin Neumann Lai Guan Ng Antonia Niedobitek Sussan Nourshargh Gabriel Núñez José‐Enrique O'Connor Aaron Ochel Anna Oja Diana Ordonez Alberto Orfao Eva Orlowski‐Oliver Wenjun Ouyang Annette Oxenius Raghavendra Palankar Isabel Panse Kovit Pattanapanyasat Malte Paulsen Dinko Pavlinic Livius Penter Pärt Peterson Christian Peth Jordi Petriz Federica Piancone Winfried F. Pickl Silvia Piconese Marcello Pinti A. Graham Pockley Malgorzata Justyna Podolska Zhiyong Poon Katharina Pracht Immo Prinz Carlo E. M. Pucillo Sally A. Quataert Linda Quatrini Kylie M. Quinn Helena Radbruch Tim R. D. J. Radstake Susann Rahmig Hans‐Peter Rahn Bartek Rajwa Gevitha Ravichandran Yotam Raz Jonathan A. Rebhahn Diether Recktenwald Dorothea Reimer Caetano Reis e Sousa Ester B.M. Remmerswaal Lisa Richter Laura G. Rico Andy Riddell Aja M. Rieger J. Paul Robinson Chiara Romagnani Anna Rubartelli Jürgen Ruland Armin Saalmüller Yvan Saeys Takashi Saito Shimon Sakaguchi Francisco Sala‐de‐Oyanguren Yvonne Samstag Sharon Sanderson Inga Sandrock Angela Santoni Ramon Bellmàs Sanz Marina Saresella Catherine Sautes‐Fridman Birgit Sawitzki Linda Schadt Alexander Scheffold Hans U. Scherer Matthias Schiemann Frank A. Schildberg Esther Schimisky Andreas Schlitzer Josephine Schlosser Stephan Schmid Steffen Schmitt Kilian Schober Daniel Schraivogel Wolfgang Schuh Thomas Schüler Reiner Schulte Axel Ronald Schulz Sebastian R. Schulz Cristiano Scottá Daniel Scott‐Algara David P. Sester T. Vincent Shankey Bruno Silva‐Santos Anna Katharina Simon Katarzyna M. Sitnik Silvano Sozzani Daniel E. Speiser Josef Spidlen Anders Stahlberg Alan M. Stall Natalie Stanley Regina Stark Christina Stehle Tobit Steinmetz Hannes Stockinger Yousuke Takahama Kiyoshi Takeda Leonard Tan Attila Tárnok Gisa Tiegs Gergely Toldi Julia Tornack Elisabetta Traggiai Mohamed Trebak Timothy I.M. Tree Joe Trotter John Trowsdale Maria Tsoumakidou Henning Ulrich Sophia Urbanczyk Willem van de Veen Maries van den Broek Edwin van der Pol Sofie Van Gassen Gert Van Isterdael René A.W. van Lier Marc Veldhoen Salvador Vento‐Asturias Paulo Vieira David Voehringer Hans‐Dieter Volk Anouk von Borstel Konrad von Volkmann Ari Waisman Rachael V. Walker Paul K. Wallace Sa A. Wang Xin M. Wang Michael D. Ward Kirsten A Ward‐Hartstonge Klaus Warnatz Gary Warnes Sarah Warth Claudia Waskow James V. Watson Carsten Watzl Leonie Wegener Thomas Weisenburger Annika Wiedemann Jürgen Wienands Anneke Wilharm Robert John Wilkinson Gerald Willimsky James B. Wing Rieke Winkelmann Thomas H. Winkler Oliver F. Wirz Alicia Wong Peter Wurst Jennie H. M. Yang Juhao Yang Maria Yazdanbakhsh Liping Yu Alice Yue Hanlin Zhang Yi Zhao Susanne Maria Ziegler Christina Zielinski Jakob Zimmermann Arturo Zychlinsky., These guidelines are a consensus work of a considerable number of members of the immunology and flow cytometry community. They provide the theory and key practical aspects of flow cytometry enabling immunologists to avoid the common errors that often undermine immunological data. Notably, there are comprehensive sections of all major immune cell types with helpful Tables detailing phenotypes in murine and human cells. The latest flow cytometry techniques and applications are also described, featuring examples of the data that can be generated and, importantly, how the data can be analysed. Furthermore, there are sections detailing tips, tricks and pitfalls to avoid, all written and peer‐reviewed by leading experts in the field, making this an essential research companion., This work was supported by the Netherlands Organisation for Scientific Research – Domain Applied and Engineering Sciences (NWO-TTW), research program VENI 15924. This work was funded by the Deutsche Forschungsgemeinschaft. European Union Innovative Medicines Initiative - Joint Undertaking - RTCure Grant Agreement 777357 and innovation program (Grant Agreement 695551).
- Published
- 2019
- Full Text
- View/download PDF
17. Monitoring tubular epithelial cell damage in AKI via urine flow cytometry
- Author
-
Jacob Kujat, Valerie Langhans, Hannah Brand, Paul Freund, Nina Görlich, Leonie Wagner, Diana Metzke, Sara Timm, Matthias Ochs, Andreas Grützkau, Sabine Baumgart, Christopher M. Skopnik, Falk Hiepe, Gabriela Riemekasten, Jan Klocke, and Philipp Enghard
- Abstract
IntroductionAcute kidney injury (AKI) is associated with significant morbidity and mortality. The diagnosis is currently based on urine output and serum creatinine and there is a lack of biomarkers that directly reflect tubular damage. Here, we establish flow cytometric quantification of renal epithelial cells as a potential biomarker for quantifying the severity of tubular kidney damage and for predicting AKI outcome.MethodsA total of 84 patients with AKI were included in this study, divided into an exploratory cohort (n=21) and confirmatory cohort (n=63), as well as 25 controls. Urine of patients was collected and processed within 72 hours after AKI onset. Different urinary tubular epithelial cell (TEC) populations were identified and quantified by flow cytometry (FACS). Urinary cell counts were analyzed regarding AKI severity defined by KDIGO stage as well as renal recovery, length of hospital stay and occurrence of MAKE-30 events.ResultsUrinary TEC counts correlated with stages of AKI based on KDIGO classification and were significantly enriched in patients with AKI compared to healthy donors and inpatient controls in both cohorts. Furthermore, both proximal and distal TEC (pTEC, dTEC) counts performed well in identification of patients with AKI regardless of stage. Urinary amounts of pTEC and dTEC showed a strong correlation, with predominance of dTEC. Higher numbers of TEC were associated with extended length of hospital stay, while elevated pTEC counts were associated with the occurrence of MAKE-30 events. Follow-up measurements showed decreasing amounts of urinary TEC after AKI recovery over several days.ConclusionThe amount of urinary TEC directly reflects severity of tissue damage in human AKI. Our protocol furthermore provides a basis for a deeper phenotypic analysis of urinary TEC populations.
- Published
- 2022
- Full Text
- View/download PDF
18. Planning in the Face of Extraordinary Uncertainty: Lessons from the COVID-19 Pandemic
- Author
-
Stefan Siedentop, Sabine Baumgart, Thomas Weith, and Oliver Ibert
- Subjects
2019-20 coronavirus outbreak ,Economic growth ,Coronavirus disease 2019 (COVID-19) ,Political science ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Geography, Planning and Development ,Pandemic ,Face (sociological concept) ,ddc:710 - Published
- 2022
19. Destinations fostering older adults' walking for transport: a cross-sectional study from Germany
- Author
-
Pia Hasselder, Tanja Brüchert, Sabine Baumgart, and Gabriele Bolte
- Subjects
Cross-Sectional Studies ,Residence Characteristics ,Germany ,Humans ,Environment Design ,Independent Living ,Walking ,Geriatrics and Gerontology ,Aged - Abstract
Background Having destinations within walking distance can encourage older people to walk. Yet, not all destinations may be equally important. Little is known about the types of destinations fostering older adults’ walking for transport in small and medium-sized towns and rural communities. The aim of this study was to explore the associations between the availability of different destinations and walking for transport among older adults living in communities with less than 100,000 inhabitants. Methods Between May and September 2019, self-reported data from 2242 older adults (≥ 65 years) living in the Metropolitan Region Northwest (Germany) were collected within the project AFOOT – Securing urban mobility of an aging population. Data from 2137 study participants were eligible for this analysis. Logistic regression models were used to investigate the relationship between the perceived destination availability of 19 different destinations within a 20-min or 10-min walk from home, respectively, and the engagement in walking for transport. Crude and adjusted models were run separately for each destination and distance category. Exploratory subgroup analyses examined the associations between the availability of destinations within a 20-min walk from home and walking for transport stratified by gender, use of a walking aid, and car availability. Results The availability of each of the investigated destinations within a 20-min walk and of nearly all of these destinations within a 10-min walk from home was significantly positively associated with walking for transport in crude models. Most associations remained significant after adjustment for covariates. The strongest associations were found for the availability of small stores, pharmacy, and bakery. The availability of a bus stop showed the weakest associations and was not significantly associated with walking for transport after adjustment for covariates. Conclusions The provision of local amenities within walking distance may be a promising approach to foster older adults’ walking for transport in smaller communities with less than 100,000 inhabitants and to enable active and healthy aging in place. Further quantitative and qualitative research is needed to validate these findings and to better understand older adults’ walking behavior.
- Published
- 2021
20. Barriers, Facilitating Factors, and Intersectoral Collaboration for Promoting Active Mobility for Healthy Aging—A Qualitative Study within Local Government in Germany
- Author
-
Tanja, Brüchert, Paula, Quentin, Sabine, Baumgart, and Gabriele, Bolte
- Subjects
Aged, 80 and over ,lcsh:R ,lcsh:Medicine ,Health Promotion ,Article ,active mobility ,healthy aging ,Germany ,age-friendly environment ,Humans ,local government ,Cities ,intersectoral collaboration ,Aged - Abstract
The promotion of walking and cycling to stay active and mobile offers great potential for healthy aging. Intersectoral collaboration for age-friendly urban planning is required in local government to realize this potential. Semi-structured interviews were conducted with the heads of planning and public health departments in city and district administrations of a Metropolitan Region in Germany to identify factors influencing action on the cross-cutting issue of active mobility for healthy aging. Although some administrations are working on the promotion of active mobility, they consider neither the needs of older people nor health effects. A lack of human resources and expertise, mainly due to the low priority placed on the issue, are described as the main barriers for further strategic collaboration. Furthermore, the public health sector often focuses on pathogens as the cause of morbidity and mortality, reducing their acceptance of responsibility for the topic. Facilitating factors include the establishment of new administrative structures, projects with rapid results that create awareness and credibility among citizens and politicians, additional staff with expertise in health promotion, and political commitment. In the future, new administrative structures for intersectoral collaboration are needed in order to consider various perspectives in complex developments, such as healthy aging, and to benefit from synergies.
- Published
- 2021
21. Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
- Author
-
Christian Brandt, Bettina Löffler, Sabine Hahnfeld, Philipp A. Reuken, Nico Andreas, Sabine Baumgart, Michael Bauer, Mathias W. Pletz, Thomas Kamradt, and Andreas Stallmach
- Subjects
Cancer Research ,2019-20 coronavirus outbreak ,Lymphoma ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Host (biology) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Hematology ,medicine.disease ,Virology ,Oncology ,Correspondence ,Infectious diseases ,Medicine ,business - Published
- 2021
22. Futures of urban transport beyond the car
- Author
-
John Mpemba Lukenangula and Sabine Baumgart
- Subjects
Financial economics ,Economics ,Futures contract - Published
- 2020
- Full Text
- View/download PDF
23. Introduction
- Author
-
Nadine Appelhans, Wolfgang Scholz, and Sabine Baumgart
- Published
- 2020
- Full Text
- View/download PDF
24. Transport Planning and Mobility in Urban East Africa
- Author
-
Wolfgang Scholz, Sabine Baumgart, and Nadine Appelhans
- Subjects
Transportation planning ,Geography ,East africa ,Environmental planning - Published
- 2020
- Full Text
- View/download PDF
25. Concluding reflections
- Author
-
Nadine Appelhans, Wolfgang Scholz, and Sabine Baumgart
- Published
- 2020
- Full Text
- View/download PDF
26. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis
- Author
-
Pawel Durek, Philipp Enghard, Sabine Baumgart, Henrik E. Mei, Thomas Rose, Andreas Grützkau, Anette Peddinghaus, and Martina Bertolo
- Subjects
0301 basic medicine ,Male ,Biopsy ,T-Lymphocytes ,Lupus nephritis ,systemic lupus – erythematosus ,CD38 ,Urine ,Kidney ,Lymphocyte Activation ,0302 clinical medicine ,Immunology and Allergy ,Medicine ,Lupus Erythematosus, Systemic ,Original Research ,urinary leukocytes ,Middle Aged ,Prognosis ,3. Good health ,medicine.anatomical_structure ,Disease Progression ,Biomarker (medicine) ,Female ,lcsh:Immunologic diseases. Allergy ,mass cytometry ,Adult ,lupus nephritis biomarker ,Urinary system ,Immunology ,CD11c ,Immunophenotyping ,Diagnosis, Differential ,03 medical and health sciences ,Young Adult ,Immune system ,Humans ,Mass cytometry ,Lymphocyte Count ,lupus nephritis ,business.industry ,Macrophages ,medicine.disease ,030104 developmental biology ,Early Diagnosis ,business ,lcsh:RC581-607 ,Immunologic Memory ,Biomarkers ,030215 immunology - Abstract
Non-invasive biomarkers are necessary for diagnosis and monitoring disease activity in lupus nephritis (LN) to circumvent risks and limitations of renal biopsies. To identify new non-invasive cellular biomarkers in the urine sediment of LN patients, which may reflect kidney inflammation and can be used to predict treatment outcome, we performed in-depth urinary immune cell profiling by mass cytometry. We established a mass cytometric workflow to comparatively analyze the cellular composition of urine and peripheral blood (PB) in 13 patients with systemic lupus erythematosus (SLE) with active, biopsy-proven proliferative LN. Clinical and laboratory data were collected at the time of sampling and 6 months after induction of therapy in order to evaluate the clinical response of each patient. Six patients with different acute inflammatory renal diseases were included as comparison group. Leukocyte phenotypes and composition differed significantly between urine and paired PB samples. In urine, neutrophils and monocytes/macrophages were identified as the most prominent cell populations comprising together about 30%–83% of nucleated cells, while T and B lymphocytes, eosinophils, and natural killer (NK) cells were detectable at frequencies of
- Published
- 2020
27. F.3.2 Fünf Leibniz-Institute für Raumforschung (ARL; IRS; IÖR; IfL; ILS-assoziiert)Sabine Baumgart
- Author
-
Sabine Baumgart
- Published
- 2020
- Full Text
- View/download PDF
28. Stadtentwicklung
- Author
-
Sabine Baumgart
- Published
- 2020
- Full Text
- View/download PDF
29. Strategische Entwicklungsansätze in kleineren Städten
- Author
-
Sabine Baumgart and Andrea Rüdiger
- Abstract
Der Beitrag von Sabine Baumgart und Andrea Rudiger reflektiert die Abhangigkeit der Stadtgrose in Bezug auf strategische Entwicklungsansatze im Rahmen des Stadtumbaus in Klein- und Mittelstadten in Nordrhein-Westfalen. Denn es zeigt sich, dass die Problemlagen, die strategischen Losungsansatze und auch die Operationalisierung sich in manchen Bereichen von denen groserer Stadte unterscheiden.
- Published
- 2020
- Full Text
- View/download PDF
30. Gesundheit in der Stadtplanung : Instrumente, Verfahren, Methoden
- Author
-
Sabine Baumgart, Andrea Rüdiger, Sabine Baumgart, and Andrea Rüdiger
- Subjects
- Public health, City planning
- Abstract
Städte waren von jeher Orte, die vor Gefahren aus dem Umland schützten. Sie brachten aber auch neue Gefährdungen durch Krankheiten und Unfälle hervor. Gesundheitsschutz und Gesundheitsvorsorge sind daher traditionell eng mit räumlicher Planung verknüpft, die zwischen unterschiedlichen Raumansprüchen und möglichen Nutzungskonflikten abwägt. Um gesundheitsrelevante Aspekte, Themen und Handlungsfelder zu erkennen, müssen relevante Perspektiven miteinander verknüpft werden. Zur Erweiterung von Handlungsoptionen für eine gesunde Stadt ist es sinnvoll, raumbezogene Regelwerke in den Gestaltungsauftrag der Akteure räumlicher Planung und politischer Entscheider•innen einzubeziehen. Die »Edition Nachhaltige Gesundheit in Stadt und Region« wird unterstützt von der Fritz und Hildegard Berg-Stiftung im Stifterverband.
- Published
- 2022
31. Safety and feasibility of sutureless pars-plana vitrectomy in sub-Tenon anesthesia (SAFE-VISA): a prospective study
- Author
-
Tibor Lohmann, Sabine Baumgarten, Julia Prinz, Peter Walter, and Antonis Koutsonas
- Subjects
Retina ,Retinal surgery ,Vitreoretinal surgery ,Local anesthesia ,Sub-Tenon anesthesia ,General anesthesia ,Medicine - Abstract
Abstract Background To determine the safety and feasibility of sutureless pars-plana vitrectomy (ppV) in sub-Tenon anesthesia. Methods In this prospective study. Pain and anxiety at various times after ppV using a visual analogue scale (VAS) and Wong-Baker-FACES scale as well as visual sensations during surgery were investigated. The surgeon evaluated motility, chemosis, overall feasibility. Results ppV was performed on 67 eyes (33 sub-Tenon anesthesia, 34 general anesthesia). Pain during surgery in sub-Tenon anesthesia was 1.8 ± 2.2 (0.0–8.0), anxiety was 2.3 ± 2.2 (0.0–8.5). There was a moderate correlation between pain and anxiety (R 2 = 0.58). Comparing sub-Tenon and general anesthesia no difference in pain perception was found the day after surgery. 27.3% of patients saw details, 21.2% saw colors, 90.1% saw light/motion perception, 3.0% had no light perception. Median chemosis after surgery was 1.0 (IQR = 1.0). Median motility of the eye during surgery was 1.0 (IQR = 1.0), median grade was 1.0 (IQR = 1.0). 24.2% of patients showed subconjunctival hemorrhage during or after surgery. Conclusions Sutureless pars-plana vitrectomy in sub-Tenon anesthesia was performed safely, with pain and anxiety levels tolerable for the patients and without the necessity for presence of an anesthesiologist. With 88.9% of patients willing to undergo vitreoretinal surgery in sub-Tenon anesthesia again, we recommend it as a standard option. Trial registration This study was approved by the Institutional Ethical Review Board of the RWTH Aachen University (EK 111/19). This study is listed on clinicaltrials.gov (ClinicalTrials.gov identifier: NCT04257188, February 5th 2020).
- Published
- 2023
- Full Text
- View/download PDF
32. Improving the consideration of human health in environmental planning and decision-making – perspectives from Germany
- Author
-
Sabine Baumgart, Monika Machtolf, and Joachim Hartlik
- Subjects
business.industry ,Geography, Planning and Development ,Environmental resource management ,010501 environmental sciences ,Management, Monitoring, Policy and Law ,01 natural sciences ,language.human_language ,German ,03 medical and health sciences ,Human health ,0302 clinical medicine ,language ,Environmental science ,030212 general & internal medicine ,business ,Environmental planning ,0105 earth and related environmental sciences - Abstract
The effects of projects, plans or programmes on human health are currently often dealt with unsatisfactorily in terms of the indicators and methods used in current German environmental assessments ...
- Published
- 2017
- Full Text
- View/download PDF
33. Dual-labelled antibodies for flow and mass cytometry: A new tool for cross-platform comparison and enrichment of target cells for mass cytometry
- Author
-
Andreas Grützkau, Susanne Krauthäuser, Silke Stanislawiak, Anette Peddinghaus, Axel Schulz, Sarah Gillert, Henrik E. Mei, Christian Dose, Sabine Baumgart, and Heike Hirseland
- Subjects
0301 basic medicine ,CD4 antigen ,T-Lymphocytes ,Plasma Cells ,Immunology ,Immunophenotyping ,Flow cytometry ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Antigen ,Labelling ,medicine ,Humans ,Immunology and Allergy ,Mass cytometry ,Antigens ,Fluorescent Dyes ,Staining and Labeling ,biology ,medicine.diagnostic_test ,Antibodies, Monoclonal ,Flow Cytometry ,Fluorescence ,Molecular biology ,030104 developmental biology ,chemistry ,CD4 Antigens ,biology.protein ,Antibody ,Fluorescein-5-isothiocyanate ,030215 immunology - Abstract
Antibody conjugates applicable in both conventional flow and mass cytometry would offer interesting options for cross-platform comparison, as well as the enrichment of rare target cells by conventional flow cytometry (FC) sorting prior to deep phenotyping by mass cytometry (MC). Here, we introduce a simple method to generate dual fluorochrome/metal-labelled antibodies by consecutive orthogonal labelling. First, we compared different fluorochrome-conjugated antibodies specific for CD4, such as FITC, Vio667, VioGreen or VioBlue for their compatibility with the conventional secondary MAXPAR® labelling protocol. After labelling with 141 Pr, the fluorescence emission spectra of all fluorochromes investigated retained their characteristics, and CD4 dual conjugates (DCs) provided consistent results in immune phenotyping assays performed by FC and MC. The phenotypical composition of CD4+ T-cells was maintained after enrichment by FC sorting using different CD4 DCs. Finally, magnetic cell depletion was combined with FC sorting using CD19-VioBlue-142 Nd, CD20-VioGreen-147 Sm, CD27-Cy5-167 Er and CD38-Alexa488-143 Nd DC to enrich rare human plasmablasts to purities >80%, which allowed a subsequent deep phenotyping by MC. In conclusion, DCs have been successfully established for direct assay comparison between FC and MC, and help to minimise MC data acquisition time for deep phenotyping of rare cell subsets.
- Published
- 2017
- Full Text
- View/download PDF
34. Intersectoral collaboration of public health and urban planning for promotion of mobility and healthy ageing: protocol of the AFOOT project
- Author
-
Sabine Baumgart, Paula Quentin, Gabriele Bolte, and Tanja Brüchert
- Subjects
medicine.medical_specialty ,Interview ,business.industry ,media_common.quotation_subject ,Public health ,Public Health, Environmental and Occupational Health ,Equity (finance) ,030204 cardiovascular system & hematology ,Public relations ,Social engagement ,Urban Studies ,03 medical and health sciences ,0302 clinical medicine ,Promotion (rank) ,Urban planning ,Political science ,medicine ,030212 general & internal medicine ,Intersectoral Collaboration ,business ,Built environment ,media_common - Abstract
Maintenance of physical activity and mobility is a crucial factor for healthy ageing and ageing in place. The built environment can either promote or hinder active transportation, and also affect social participation and independence. Although public health researchers have been examining this relationship for years, in Germany it is neither a commonly addressed topic of public health authorities nor explicitly in the focus of urban planning departments. The AFOOT project pursues an inter- and transdisciplinary approach to identify entry points for health and equity assessment in urban planning procedures, with a particular focus on small- and medium-sized towns. The final goal is to develop a guide for intersectoral policy action. The project methodology includes document analysis, interviewing of experts, workshops and the simulation of implementation by role-playing games with local stakeholders. Against the background of the ‘Health in All Policies’ strategy, encouragement of a transdisciplina...
- Published
- 2017
- Full Text
- View/download PDF
35. Power-shifts in the organizational landscapes of transport provision
- Author
-
Nadine Appelhans and Sabine Baumgart
- Subjects
Power (social and political) ,Mass rapid transit ,Flexibility (engineering) ,Framing (social sciences) ,Dar es salaam ,Business ,Business model ,Environmental planning ,Diversity (business) ,Variety (cybernetics) - Abstract
This chapter aims to overcome binary descriptions of transport systems in Nairobi and Dar es Salaam by framing the relations of existing local transport provision as “heterarchies”. Drawing on the case of Jakarta, Doreen Lee describes how “traffic provides the temporal infrastructure that governs the flow of living and leisure, and the patterning of individual desires and struggles by creating a sensation of ‘being traffic’”. The diversity of actors and stakeholders in the transport provision of informal and decentral modes of transport in combination with the variety of formal regulatory institutions, leads to a variety of aims, business models, passenger bases, fare systems, employment, and standards in both locations. The aims regarding improving the reach, accessibility, and flexibility of the transport system in Nairobi and Dar es Salaam serve to justify a reorganization of the current heterarchic organization of the transport sector and to introduce mass rapid transit systems” systems.
- Published
- 2019
- Full Text
- View/download PDF
36. Mass Cytometry Enabling Absolute and Fast Quantification of Silver Nanoparticle Uptake at the Single Cell Level
- Author
-
Sabine Baumgart, Anette Peddinghaus, Andreas Luch, Doreen Wittke, Andrea Haase, Ana López-Serrano Oliver, Norbert Jakubowski, and Andreas Grützkau
- Subjects
Silver ,THP-1 Cells ,010401 analytical chemistry ,Metal Nanoparticles ,Cellular level ,010402 general chemistry ,Mass spectrometry ,Flow Cytometry ,01 natural sciences ,Silver nanoparticle ,0104 chemical sciences ,Analytical Chemistry ,Silver nitrate ,chemistry.chemical_compound ,chemistry ,Nanotoxicology ,Calibration ,Biophysics ,Humans ,Mass cytometry ,Single-Cell Analysis ,Intracellular - Abstract
In the last decades, significant efforts have been made to investigate possible cytotoxic effects of metallic nanoparticles (NPs). Methodologies enabling precise information regarding uptake and intracellular distribution of NPs at the single cell level remain to be established. Mass cytometry (MC) has been developed for high-dimensional single cell analyses and is a promising tool to quantify NP-cell interactions. Here, we aim to establish a new MC-based quantification procedure to receive absolute numbers of NPs per single cell by using a calibration that considers the specific transmission efficiency (TE) of suspended NPs. The current MC-quantification strategy accept TE values of complementary metal solutions. In this study, we demonstrate the different transmission behavior of 50 nm silver NPs (AgNP) and silver nitrate solution. We have used identical AgNPs for calibration as for in vitro-differentiated macrophages (THP-1 cell line) in a time- and dose-dependent manner. Our quantification relies on silver intensities measuring AgNPs in the same detection mode as the cells. Results were comparable with the TE quantification strategy using AgNPs but differed when using ionic silver. Furthermore, intact and digested cell aliquots were measured to investigate the impact of MC sample processing on the amount of AgNPs/cell. Taken together, we have provided a MC-specific calibration procedure to precisely calculate absolute numbers of NPs per single cell. Combined with its unique feature of multiplexing up to 50 parameters, MC provides much more information on the single cell level than single cell-inductively coupled plasma mass spectrometry (SC-ICPMS) and, therefore, offers new opportunities in nanotoxicology.
- Published
- 2019
37. Stabilizing Antibody Cocktails for Mass Cytometry
- Author
-
Sabine Baumgart, Axel R. Schulz, Marie Urbicht, Julia Schulze, Henrik E. Mei, and Andreas Grützkau
- Subjects
0301 basic medicine ,Histology ,Immune monitoring ,Lanthanoid Series Elements ,Mass Spectrometry ,Immunophenotyping ,Pathology and Forensic Medicine ,Immune profiling ,03 medical and health sciences ,0302 clinical medicine ,Isotopes ,Humans ,Mass cytometry ,Chromatography ,biology ,Chemistry ,Antibodies, Monoclonal ,Cell Biology ,Flow Cytometry ,Staining ,Multiple data ,030104 developmental biology ,030220 oncology & carcinogenesis ,Leukocytes, Mononuclear ,biology.protein ,Single-Cell Analysis ,Antibody ,Cytometry ,Palladium - Abstract
Mass cytometry is increasingly employed in larger immune profiling studies involving data acquisitions across several days and multiple sites. For gaining a maximum of information from respective data by computational analyses, several techniques have been developed to minimize noise in mass cytometric data sets, such as sample banking, standardized instrument setup, sample barcoding, and signal normalization. However, the repeated preparation of cocktails composed of isotope-tagged antibodies remained a significant source of error. We here show that premixed antibody cocktails fail to deliver expected staining patterns when stored at 4°C for 4 weeks. As a solution, we developed and tested a cryopreservation method for highly multiplexed antibody cocktails for mass cytometry including lanthanide, palladium, and platinum conjugates that yielded stable staining patterns for at least 9 months when stored at temperatures below -80°C. Using frozen aliquots of antibody cocktails is an economic and flexible approach to significantly improve data consistency in large mass cytometry studies with repetitive staining/measurement cycles spanning several days or involving multiple data acquisition sites. © 2019 International Society for Advancement of Cytometry.
- Published
- 2019
- Full Text
- View/download PDF
38. Osmium-Labeled Microspheres for Bead-Based Assays in Mass Cytometry
- Author
-
Henrik E. Mei, Heike Hirseland, Tyler Burns, Thomas Rose, Lisa Budzinski, Axel R. Schulz, and Sabine Baumgart
- Subjects
Adult ,Male ,Receptor expression ,Immunology ,Cell ,T-Lymphocytes, Regulatory ,Flow cytometry ,Immunological synapse ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Immune system ,medicine ,Humans ,Lupus Erythematosus, Systemic ,Immunology and Allergy ,Mass cytometry ,Aged ,Lupus erythematosus ,Staining and Labeling ,medicine.diagnostic_test ,HLA-DR Antigens ,Middle Aged ,Flow Cytometry ,Osmium ,medicine.disease ,Molecular biology ,Microspheres ,medicine.anatomical_structure ,Gene Expression Regulation ,Osmium tetroxide ,chemistry ,Polystyrenes ,Female ,Immunologic Memory ,030215 immunology - Abstract
Polystyrene beads are broadly applied in flow cytometry. Implementing bead-based assays in mass cytometry is desired but hampered by the lack of an elemental label required for their detection. In this study, we introduce stable osmium tetroxide labeling as a universal approach for generating functionalized beads readily detectable by mass cytometry. We demonstrate the utility of osmium-labeled beads for signal spillover compensation in mass cytometry, and, strikingly, their application in quantitative Ab-binding capacity assays combined with high-dimensional profiling of human PBMC enabled the systematic assessment of receptor expression profiles across large numbers of cellular phenotypes. This analysis confirmed increased monocytic Siglec-1 expression in active systemic lupus erythematosus patients and, additionally, revealed interrelated reductions of CD4 expression by regulatory and memory CD4 T cells and HLA-DR expression by myeloid dendritic cells, pointing toward defective cross-talk at the immunological synapse that may limit immune responses in systemic lupus erythematosus. By converting conventional flow cytometry beads into beads suitable for mass cytometry, our approach paves the way toward the broad implementation of bead-based assays in high-dimensional cell profiling studies by mass cytometry in biomedical research.
- Published
- 2019
- Full Text
- View/download PDF
39. Transport Planning and Mobility in Urban East Africa
- Author
-
Nadine Appelhans, Wolfgang Scholz, Sabine Baumgart, Nadine Appelhans, Wolfgang Scholz, and Sabine Baumgart
- Subjects
- Urban transportation--Africa, East, Urban transportation--Africa, East--Planning
- Abstract
This book critically explores the relationship between mobility patterns, transport provision and urban development in East African cities.Bringing together contributions on the futures of mobility in urban East Africa, the chapters examine transport provision, mobility patterns, location-specific modes of transport and transformative factors for transport and mobility in the rapidly urbanising region. The book outlines different mobility needs to be addressed in transport planning to serve and shape the respective cities and examines the decision-making process in transport planning and the level of accountability to the public. The contributors show the dialectic between innovation in transport/mobility and urban development under rapid urbanisation and discusses how to practically integrate mobility and transport provision into urban development.This book will be of interest to scholars in urban planning, transport planning, transport geography, social sciences and African studies.
- Published
- 2020
40. Characterization of In-House Produced Mono- and Polyclonal Antibodies Against Soy for Component-Resolved Allergen Analysis
- Author
-
Michael Wiederstein, Manuela Fuehrer, Kathrin Lauter, and Sabine Baumgartner
- Subjects
Nutrition. Foods and food supply ,TX341-641 - Abstract
In recent years, food allergies have emerged as a significant global health concern that affect an increasing percentage of the population. Despite being under investigation and discussed as a major or minor elicitor of food allergies, soybean remains a notable allergenic food source, affecting approximately 0.3%–3% of people worldwide, with a higher prevalence in Asian countries. Allergic reactions to soy can manifest as mild symptoms or progress to severe, life-threatening conditions such as anaphylaxis. Consequently, there is an urgent need for the specific detection of soy allergens in food to mitigate the risk of inadvertent exposure and associated allergic reactions. State-of-the-art methods for detecting food allergens include immunoassays utilizing either food source- or, ideally, allergen-specific antibodies, along with mass spectrometry for detecting specific protein-derived peptides. However, many commercially available immunoassays predominantly utilize polyclonal antibodies, which can confirm the presence of the entire food source but lack specificity for individual allergens. In response to this limitation, the aim is to develop specific monoclonal antibodies targeting individual soy allergens. These antibodies enable “component-resolved analysis” of food samples, aligning with the emerging trend of component-resolved diagnosis in allergy research. The generated monoclonal antibodies not only offer the ability to detect individual soy allergens in food and raw materials but also serve as valuable tools for quality and safety control of materials used in oral immunotherapy and allergy diagnosis. This improvement contributes significantly to aiding people with soy allergies and can be adapted for other food allergenic sources. This advancement represents a pivotal step toward enhancing the precision and comprehensiveness of allergen detection methodologies, addresses the specific challenges faced by individuals with soy allergies, and lays the foundation for broader applications to other food allergenic sources.
- Published
- 2024
- Full Text
- View/download PDF
41. OMIP-034: Comprehensive immune phenotyping of human peripheral leukocytes by mass cytometry for monitoring immunomodulatory therapies
- Author
-
Andreas Grützkau, Anette Peddinghaus, Sabine Baumgart, Ursula Schulte-Wrede, and Henrik E. Mei
- Subjects
0301 basic medicine ,Histology ,chemical and pharmacologic phenomena ,Immune monitoring ,medicine.disease_cause ,Pathology and Forensic Medicine ,Autoimmunity ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,immune system diseases ,medicine ,Mass cytometry ,skin and connective tissue diseases ,business.industry ,Cell Biology ,biochemical phenomena, metabolism, and nutrition ,medicine.disease ,Peripheral ,Clinical trial ,030104 developmental biology ,Immunology ,bacteria ,Biomarker (medicine) ,business ,Rheumatism ,030215 immunology - Abstract
Keywords: mass cytometry; panel design; mass-response characteristic; human blood leukocytes; immune phenotyping; immune monitoring; autoimmunity; rheumatism; systemic lupus erythematosus (SLE); biomarker and clinical trial
- Published
- 2016
- Full Text
- View/download PDF
42. Silver nanoparticles for the detection of cell surface antigens in mass cytometry
- Author
-
Andreas Grützkau, Sabine Baumgart, Silke Stanislawiak, Axel R. Schulz, and Henrik E. Mei
- Subjects
0301 basic medicine ,Histology ,medicine.diagnostic_test ,Cell Biology ,Biology ,Molecular biology ,Primary and secondary antibodies ,Silver nanoparticle ,Pathology and Forensic Medicine ,Flow cytometry ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Single-cell analysis ,Antigen ,Biotinylation ,medicine ,Biophysics ,biology.protein ,Mass cytometry ,Cytometry ,030215 immunology - Abstract
Mass cytometry has pioneered >40-parameter single-cell analyses that allow for the characterization of complex cellular networks at unprecedented depth. Up to 135 parameters can be simultaneously detected, but limited availability of metal tags suitable for labeling of specific probes prevents optimal exploitation of the analytical capacity of mass cytometers. To this end, we here establish the application of elemental silver nanoparticles (AgNP) of different size for reporting cell surface antigens on human leukocytes in mass cytometry assays. The mass channels at 107 Da and 109 Da are uniquely occupied by silver isotopes and do not interfere with other mass cytometry reagents. Streptavidin-coated AgNP (SA-AgNP) facilitated distinct and specific detection of various antigens, such as CD8, CD244 and CD294 on peripheral blood leukocytes pre-incubated with respective biotinylated primary antibodies. Signal intensities elicited by 40 nm-sized AgNP allowed specific detection of the low abundance antigen CD25 on both, peripheral blood regulatory T cells and CD25lo CD127+ CD4+ T cells, enabling their distinct clustering in viSNE plots. SA-AgNP were of high elemental purity, showed minor background binding to cells in immunoassays, and were compatible with previously established staining protocols for PBMC and leukocytes, facilitating their use in complex mass cytometry panels. Considering the synthesis of AgNP from isotopically purified silver, the usage of AgNP extends the analytical capacity of mass cytometry panels by one, prospectively two, additional parameters, suitable for the detection of cellular targets of low abundance. © 2016 International Society for Advancement of Cytometry.
- Published
- 2016
- Full Text
- View/download PDF
43. Determinanten des Online-Einkaufs – eine empirische Studie in sechs nordrhein-westfälischen Stadtregionen
- Author
-
Nina Hangebruch, Christian Krajewski, Cordula Neiberger, Björn Zucknik, Verena Texier-Ast, Linus Holtermann, Claus-C. Wiegandt, Frank Osterhage, Sabine Baumgart, Matthias Mensing, and Klaus Zehner
- Subjects
0502 economics and business ,05 social sciences ,Geography, Planning and Development ,0211 other engineering and technologies ,050211 marketing ,021107 urban & regional planning ,02 engineering and technology ,Humanities - Abstract
Einzelhandel findet heute nicht nur in den Stadt- und Stadtteilzentren bzw. in den Einkaufszentren am Rande der Stadte statt, sondern zunehmend auch im Internet. Der Beitrag untersucht, welche Determinanten ausschlaggebend sind, im stationaren Einzelhandel bzw. im Online-Handel einzukaufen. Die Ergebnisse basieren auf einer Befragung von rund 2.900 Personen in den sechs nordrhein-westfalischen Stadtregionen Aachen, Bochum, Bonn, Dortmund, Munster und Koln. In Abhangigkeit der Entfernung zur jeweiligen Innenstadt wurde in insgesamt 26 Untersuchungsgebieten befragt. In allen sechs Stadtregionen zeigt sich, dass nicht die raumlichen, sondern ausgewahlte demographische und soziookonomische Faktoren das Einkaufsverhalten bestimmen. Das Geschlecht, das Alter und die Lebensstile spielen beim Online-Einkauf eine wesentliche Rolle, das Einkommen ist keine beeinflussende Grose.
- Published
- 2018
- Full Text
- View/download PDF
44. StadtGesundheit/Urban Health
- Author
-
Rainer Fehr, Sabine Baumgart, Alf Trojan, GA Wiesmüller, Andrea Rüdiger, T h Claßen, A Bunte, Odile Mekel, H Köckler, and Claudia Hornberg
- Subjects
Geography ,Environmental health ,Urban health - Published
- 2018
- Full Text
- View/download PDF
45. Quantification of silver nanoparticles up-taken by single cells using inductively coupled plasma mass spectrometry in the single cell measurement mode
- Author
-
Wolfram Bremser, Sabine Flemig, Andrea Haase, Sabine Baumgart, Andreas Grützkau, Andreas Luch, Ana López-Serrano Oliver, Norbert Jakubowski, and Doreen Wittke
- Subjects
Chromatography ,Chemistry ,010401 analytical chemistry ,Cell ,Nanoparticle ,02 engineering and technology ,Cellular level ,021001 nanoscience & nanotechnology ,01 natural sciences ,Silver nanoparticle ,0104 chemical sciences ,Analytical Chemistry ,medicine.anatomical_structure ,Single-cell analysis ,medicine ,0210 nano-technology ,Quantitative analysis (chemistry) ,Inductively coupled plasma mass spectrometry ,Spectroscopy - Abstract
The impact of nanoparticles, NPs, at the single cell level has become a major field of toxicological research and different analytical methodologies are being investigated to obtain biological and toxicological information to better understand the mechanisms of cell–NP interactions. Here, inductively coupled plasma mass spectrometry in the single cell measurement mode (SC-ICP-MS) is proposed to study the uptake of silver NPs, AgNPs, with a diameter of 50 nm by human THP-1 monocytes in a proof-of-principle experiment. The main operating parameters of SC-ICP-MS have been optimized and applied for subsequent quantitative analysis of AgNPs to determine the number of particles in individual cells using AgNP suspensions for calibration. THP-1 cells were incubated with AgNP suspensions with concentrations of 0.1 and 1 μg mL−1 for 4 and 24 hours. The results reveal that the AgNP uptake by THP-1 monocytes is minimal at the lower dose of 0.1 μg mL−1 (roughly 1 AgNP per cell was determined), whereas a large cell-to-cell variance dependent on the exposure time is observed for a 10 times higher concentration (roughly 7 AgNPs per cell). The method was further applied to monitor the AgNP uptake by THP-1 cells differentiated macrophages incubated at the same AgNP concentration levels and exposure times demonstrating a much higher AgNP uptake (roughly from 9 to 45 AgNPs per cell) that was dependent on exposure concentration and remained constant over time. The results have been compared and validated by sample digestion followed by ICP-MS analysis as well as with other alternative promising techniques providing single cell analysis.
- Published
- 2018
- Full Text
- View/download PDF
46. Translation of urban planning models: Planning principles, procedural elements and institutional settings
- Author
-
Wolfgang Scholz, Shahadat Hossain, and Sabine Baumgart
- Subjects
biology ,business.industry ,Corporate governance ,Environmental resource management ,Land-use planning ,Public administration ,biology.organism_classification ,Colonialism ,Urban Studies ,Power (social and political) ,Tanzania ,Urban planning ,Political science ,Regional planning ,business ,Land tenure - Abstract
This paper presents the process of the translation and instrumentalisation of colonial urban planning principles into contemporary urban planning laws and instruments in Dar es Salaam. Based on a historical reading of the urban planning institutions and empirical references about current urban planning practices in this city it develops three main claims. First, there is a continuation of colonial planning institutions in the post-colonial Dar es Salaam. The shift of power from the colonial authority to the national state of Tanzania did not greatly impact on the planning institutions and practices in this city. Second, colonial urban planning legacies still dominate the planning institutions and practices in the post-colonial Dar es Salaam, however in different forms. They are now shaped by different sets of actors, follow economic logics, benefit only small groups of the economically privileged at the cost of the majority, and support the accumulation of power of the nation-state authorities. Third, the urban consequences and the urban planning institutions and practices of Dar es Salaam are interrelated; each is a result of the process of translation and instrumentalisation of colonial urban planning principles in the post-colonial setting accompanied by poor management and governance processes as well as the contradictions in the land tenure system that characterise this city. Acknowledging the urban consequences as being conditioned by the intense interplay between planning institutions and practice, and urban management and governance, this paper shows how the continued presence of colonial planning principles in the shaping of post-colonial planning practices may contribute to present-day urban consequences in Dar es Salaam.
- Published
- 2015
- Full Text
- View/download PDF
47. immunoClust-An automated analysis pipeline for the identification of immunophenotypic signatures in high-dimensional cytometric datasets
- Author
-
Andreas Grützkau, Pawel Durek, Sabine Baumgart, Till Sörensen, and Thomas Häupl
- Subjects
Histology ,Source code ,business.industry ,Event (computing) ,Computer science ,media_common.quotation_subject ,Cell Biology ,Bioinformatics ,computer.software_genre ,Pipeline (software) ,Pathology and Forensic Medicine ,Identification (information) ,Expectation–maximization algorithm ,Mass cytometry ,Personalized medicine ,Data mining ,business ,Cluster analysis ,computer ,media_common - Abstract
Multiparametric fluorescence and mass cytometry offers new perspectives to disclose and to monitor the high diversity of cell populations in the peripheral blood for biomarker research. While high-end cytometric devices are currently available to detect theoretically up to 120 individual parameters at the single cell level, software tools are needed to analyze these complex datasets automatically in acceptable time and without operator bias or knowledge. We developed an automated analysis pipeline, immunoClust, for uncompensated fluorescence and mass cytometry data, which consists of two parts. First, cell events of each sample are grouped into individual clusters. Subsequently, a classification algorithm assorts these cell event clusters into populations comparable between different samples. The clustering of cell events is designed for datasets with large event counts in high dimensions as a global unsupervised method, sensitive to identify rare cell types even when next to large populations. Both parts use model-based clustering with an iterative expectation maximization algorithm and the integrated classification likelihood to obtain the clusters. A detailed description of both algorithms is presented. Testing and validation was performed using 1) blood cell samples of defined composition that were depleted of particular cell subsets by magnetic cell sorting, 2) datasets of the FlowCAP III challenges to identify populations of rare cell types and 3) high-dimensional fluorescence and mass-cytometry datasets for comparison with conventional manual gating procedures. In conclusion, the immunoClust-algorithm is a promising tool to standardize and automate the analysis of high-dimensional cytometric datasets. As a prerequisite for interpretation of such data, it will support our efforts in developing immunological biomarkers for chronic inflammatory disorders and therapy recommendations in personalized medicine. immunoClust is implemented as an R-package and is provided as source code from www.bioconductor.org.
- Published
- 2015
- Full Text
- View/download PDF
48. A guide for intersectoral policy action to promote active mobility by community design
- Author
-
Sabine Baumgart, Paula Quentin, Gabriele Bolte, and Tanja Brüchert
- Subjects
Process management ,Action (philosophy) ,Public Health, Environmental and Occupational Health ,Business ,Active mobility ,Community design - Published
- 2017
- Full Text
- View/download PDF
49. Immobilienwirtschaft und Raumplanung
- Author
-
Sabine Baumgart
- Abstract
Raumplanung hat die Aufgabe der Entwicklung, Ordnung und Sicherung des Raumes. Dies basiert auf dem Grundsatz einer umfassenden nachhaltigen Entwicklung, die „die sozialen, wirtschaftlichen und umweltschutzenden Anforderungen auch in Verantwortung gegenuber kunftigen Generationen miteinander in Einklang bringt, und eine dem Wohl der Allgemeinheit dienende sozialgerechte Bodennutzung“ [1] gewahrleistet [2].
- Published
- 2017
- Full Text
- View/download PDF
50. Spaces, Rights and Resources
- Author
-
Volker Kreibich and Sabine Baumgart
- Subjects
Geography ,Megacity ,Environmental protection ,Human settlement ,Urbanization ,Environmental planning - Abstract
From city to megacity: Dhaka in Bangladesh is an example of how people living in peripheral settlements strive to secure their survival. But this “informal urbanisation” presents urban planners with enormous challenges.
- Published
- 2014
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.